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Systemic steroid hormone and intracellular signaling pathways are known to act 
cooperatively during the development of vertebrate and invertebrate epithelia. However, the 
mechanism of this interaction is poorly understood. Morphogenesis of Drosophila leg imaginal 
disc epithelia is regulated both by the steroid hormone 20-hydroxyecdysone (ecdysone) and the 
RhoA GTPase signaling pathway. Recent evidence suggests that these pathways act 
cooperatively to control imaginal disc morphogenesis. Thus, leg imaginal disc morphogenesis is 
an excellent system in which to study the interaction of steroid hormone and intracellular 
signaling pathways. We have identified mutations in three genes, 12-5, 18-5, and 31-6, with roles 
in the morphogenesis of leg epithelia. Of particular interest, these mutations interact genetically 
with each other, mutations in the RhoA signaling pathway, and the ecdysone regulated Sb-sbd 
(Stubble) transmembrane serine protease. This suggests that the 12-5, 18-5, and 31-6 gene 
products may link hormone and RhoA signaling responses. The goal of this research was to 
identify and characterize the 18-5 and 12-5 genes in order to discern the mechanistic relationship 
between the RhoA pathway and ecdysone hierarchy. 
18-5 and 12-5 were precisely mapped to molecular locations within the Drosophila 
genome utilizing a P-element recombination mapping technique. This work narrowed the 
location of the 18-5 locus to within an interval of 112 kb within the Drosophila genome 
sequence. This interval contains 17 known and predicted genes. I also mapped the location of the 
12-5 locus to a 2.6 Mb interval of the 2nd chromosome. Based on phenotypic analyses and the 
 ii
site of the molecularly mapped interval, a candidate gene for the 18-5 mutation was identified. 
Sequence analysis of the candidate gene was inconclusive and requires further analysis. Genetic 
interaction assays indicate that the 18-5 gene product acts upstream or at the level of Rho kinase 
in the RhoA signaling pathway. 
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Epithelia are one of the four primary tissues and occur in various morphological 
types to provide a wide variety of functions. These functions include: secretion, 
absorption, and sensation detection as well as the more general structural, protective and 
partitioning functions. One of the most important characteristics of epithelia is that cells 
adhere to each other to form nearly impermeable, laterally coherent sheets. Several cell 
junction types mediate cell-cell interactions in epithelia (e.g. tight junctions, gap 
junctions and desmosomes). Adherens junctions are a type of cell junctions which 
provide lateral adhesion and tension between epithelial cells to induce sheet formation. 
Cadherin and catenin proteins comprise the adherens intercellular junction while 
intracellular actin cytoskeletal elements connect neighboring adherens cell junctions 
providing tension holding the epithelial sheet together. 
The carefully coordinated multistep process of epithelial morphogenesis 
contributes to the shape and function of organs and body parts [1]. Examples of epithelial 
morphogenesis include embryonic epithelial invagination in the sea urchin, urethral tube 
development, and prostate epithelial morphogenesis in humans [2-4]. Specific signals 
trigger morphogenetic events and require an accurate coordination of cytoskeletal and 
adhesive properties. Through this process, the cell responds to changes in the actin 
cytoskeleton with structural alterations that result in a structural reorganization of the 
epithelial sheet. Normal development of these tissues is critical for the proper function of 
necessary organs, whereas abnormal development of epithilia contributes to 
developmental problems and many diseases [5, 6]. Some diseases caused by abnormal 
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epithelial development include: polycystic kidney disease, prostate carcinoma, and 
abnormal tubule formation in the mammalian urethra [3, 7, 8]. Understanding the general 
mechanisms regulating epithelial morphogenesis is fundamental to the understanding of 
the role of epithelial development in various diseases. 
Drosophila leg imaginal discs are a congruent system in which to study general 
epithelial morphogenesis. Drosophila imaginal primordia give rise to most of the adult 
epithelial structures including the adult head, thorax and appendages, and external 
genitalia [9]. Imaginal discs arise as invaginations of embryonic epithelium and grow by 
mitosis until metamorphosis, at which time, substantial morphological changes occur. 
During metamorphosis, nearly all the larval tissues are destroyed by apoptosis, while 
concurrently, adult organs and structures are derived from imaginal primordia and 
histoblast nests. 
Drosophila melanogaster imaginal disc epithelia provide an excellent model to 
study the cellular, genetic and molecular biology of the morphogenetic changes in 
epithelial sheets. Drosophila leg development is well characterized at a cell biological 
level and is highly amenable to genetic analysis. Prior to metamorphosis, leg imaginal 
discs are flattened sac-like structures composed of a columnar epithelium on one side, 
graded into a thin sheet called the peripodial epithelium and attached by a stalk to the 
inner surface of the larval epidermis [9, 10]. Precisely coordinated conformational shape 
changes within each epithelial cell stimulates the unfolding and evagination of the leg 
disc to form an elongated structure that eventually comprises the adult leg. Leg imaginal 
disc morphogenesis is initiated by systemic steroid hormone as well as intracellular RhoA 
GTPase signaling [11, 12]. Furthermore, constituent genes of the steroid and RhoA 
signaling pathways genetically interact in the developing leg suggesting an intersection 
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between a global steroid hormone response and the ubiquitous intracellular RhoA 
signaling pathway to control epithelial morphogenesis. Consequently, Drosophila 
imaginal discs make useful tools to study the intersection of hormonal and intracellular 
signaling pathways with respect to regulating epithelial morphogenesis. 
Ecdysone and Drosophila melanogaster development 
All major post-embryonic developmental transitions in Drosophila are controlled 
by systemic pulses of the steroid hormone, 20-hydroxyecdysone (hereafter referred to as 
ecdysone) [9, 11-14]. The 10 day life cycle of the holometabolous Drosophila 
melanogaster consists of discrete embryonic, larval, pupal and adult stages. The larval 
period is organized into three instars punctuated by ecdysone-induced molting. At the end 
of the third and final instar, a major increase in ecdysone titer causes the progression into 
the prepupal stage where the morphogenetic events associated with metamorphosis begin 
(Figure 1). 
Metamorphosis is divided into two stages: a brief, 12-hour prepupal period and an 
84-hour pupal period [9]. The prepupal period begins with pupariation in which the larval 
cuticle hardens to form the pupal case and imaginal discs undergo morphogenesis. Adult 
head eversion marks the start of the following 84-hour pupal period during which the 
adult cuticle is formed and the adult animal ecloses from the pupal case approximately 
192 hours after the larva hatches from the egg. 
Ecdysone is synthesized in the ring gland of larvae. The ecdysone receptor is a 
member of the nuclear hormone receptor family and acts as a heterodimer with another 
member of the same family, ultraspiracle [15]. When bound to ecdysteroids, the 
heterodimer binds directly to DNA to regulate gene expression and various 
developmental processes. A similar mechanism is exemplified in mammals in which 
estrogen binding to estrogen receptor and estrogen receptor cofactors regulates gene 
expression and morphogenesis of mammary ductal formation [16, 17]. 
Ecdysone pulses occurring in the third larval instar and in prepupae are 
developmentally relevant to this thesis. Unlike earlier larval pulses which regulate 
molting, late larval and prepupal ecdysone pulses are associated with many tissue-
specific responses including leg disc elongation [9]. The low-titer ecdysone pulse at 12 
hours post-second/third instar transition stimulates global regulatory gene networks 
which control spatial responses in larval tissues and serve to prepare the animal for 
metamorphosis. Ecdysone pulses at 48/0 hours and 60/12 hours mark the beginning of 
prepupal and pupal periods respectively triggering cell death in most larval tissues and 
morphogenesis of adult structures (Figure 1; [13, 14, 18]). 
  
Figure 1: Changes in ecdysone titer at the onset of metamorphosis.  
Transient changes in ecdysone titer are indicated. Time 48/0 represents the total time elapsed post 
2nd to 3rd instar molt (48 hours) and the beginning of the prepupal stage (0 hours). Ecdysone pulses regulate 
entry into metamorphosis. The initial stages of leg morphogenesis occur during the first six hours of the 
prepupal period after pupariation (arrow at 48/0 hours). 
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Drosophila leg morphogenesis 
Major transformations of the folded leg disc to a tubular leg occur during the first 
six hours of prepupal period, while refinements to the structure of the leg, including 
segmentation, and the differentiation of hairs and bristles occurs later in the pupal period. 
Originally, the imaginal disc cells have an anisometric conformation, with a 
greater width than length. In the elongated appendage, the cells become isometric, with 
much of their width diminished (Figure 2A; [19]). The result of this shape change is a 
lengthening and narrowing of the tubular appendage. Leg disc morphogenesis involves 
elongation of the disc and eversion to the outside of the animal, collectively referred to as 
evagination (Figure 2B; [9, 10]). The elongation and unfolding of the leg tissue is driven 
by the circumferential constriction of the epithelium. Eversion of the appendage to the 
outside of the larval epidermis then occurs by widening of the stalks and rupturing of the 
peripodial epithelium [9, 20]. These processes are coordinated by precise cell shape 
changes caused by the contraction of the apical actin-myosin belt (Figure 2D; [9, 10]). 
Bundles of actin microfilaments alternating with myosin II proteins form a ring around 
the apical end of each leg disc epithelial cell (Figure 2C and 2D). The myosin proteins 
form dimers that, when activated, provide a mechanical force which pulls on the actin 
filaments and cell-cell adherens junctions leading to apical constriction and 
morphological cell shape changes. 
 
       
Figure 2: Illustration depicting the cell shape changes during leg elongation.  
(A) The originally anisometric cells take on a more isometric shape through the process of 
epithelial morphogenensis. Six hours after pupariation, imaginal epithelia have become isometric. (B) This 
reduction in cellular width results in an elongation and narrowing of the tubular structure forming a 
rudimentary leg. (C) The morphological cell shape changes are driven by actin-myosin contraction. (D)The 
actin myosin belt connects to neighboring epithelial cells at adherens junctions and provides the force 
needed for apical circumferential constriction. 
Regulation of leg epithelial cell shape changes 
A number of genes controlling cell shape changes and presumably actin-myosin 
contractility are associated with the proper development of the adult leg and wing. Two 
gene groups influencing leg and wing epithelial morphogenesis include the ecdysone 
hormone responsive genes and genes that are not directly regulated by ecdysone [11, 12, 
21-25]. The Stubble-stubbloid serine protease (Sb-sbd) and broad family of zinc-finger 
transcription factors are examples of ecdysone hormone responsive genes which play a 
role in leg and wing development [12, 21, 22, 24, 26]. Additionally, non-hormonal 
responsive genes including RhoA GTPase and myosin II heavy chain (zipper) are 
necessary for normal leg epithelial morphogenesis [23, 27]. 
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Cell biological analysis has shown that cell shape changes are defective in Sb-sbd 
and broad mutants [19, 21]. Animals with mutations in Sb-sbd, broad, RhoA and zipper 
exhibit leg and wing malformation phenotypes (Figure 3A and 3B; [12, 23]). This 
suggests that the malformed phenotype is a good indicator of failure to alter cell shape, an 
essential part of epithelial morphogenesis. In particular, the leg malformation phenotype 
is easily scored and characterized by shortened, twisted femurs and bent tibia (Figure 
3B). Existing mutations in the genes required for cell shape changes in leg imaginal discs 
also provide invaluable research tools which can be used to screen for new genetic 
pathway components (see below). 
   
Figure 3: Image depicting the leg and wing wildtype (A and C) and malformed (B and D) 
phenotypes. 
 Wildtype legs are pictured in A, while the malformed leg phenotype is represented by short, 
twisted appendages (B). The wildtype wing is shown in C while the typical crumpled, malformed wing is 
shown in D [12]. 
RhoA GTPase signaling in imaginal discs 
The Ras superfamily of GTPases are evolutionarily conserved master regulators 
of various biological processes.  These small 20-25 kDa monomeric signaling proteins, 
numbering over 60 in mammals, fall into five major groups; Ras, Rho, Rab, Arf and Ran. 
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The Rho family consisting of Cdc42, Rac and Rho, play a special role in regulating the 
actin cytoskeleton [28-30]. In particular, the RhoA (Rho1) gene encodes RhoA-GTPase 
which acts as a molecular switch and activates downstream effector kinases. One role of 
the effector kinases is the regulation of actin-myosin cytoskeletal contraction and cell 
shape changes in many tissues including Drosophila leg and wing epithelial 
morphogenesis [31]. In Drosophila, RhoA signaling is involved in developmental 
processes as diverse as head involution, dorsal closure, and imaginal disc morphogenesis 
[11, 32-34]. Rho proteins are also involved in vertebrate cancers. Studies have shown a 
positive correlation between Rho protein levels and breast and testicular cancer diagnosis 
[6, 35, 36]. Furthermore, Rho overexpression leads to the detachment of cells from 
epithelial sheets in culture [37]. 
The Rho GTPase protein is active when bound to guanosine triphosphate (GTP) 
and inactive when GTP is hydrolyzed to guanosine diphosphate (GDP). This activity is 
modulated by guanine nucleotide exchange factors (GEFs) which activate RhoA by 
exchanging GDP bound to Rho with GTP. Conversely, GTPase activating proteins 
(GAPs) negatively regulate GTPases. GAPs operate by catalyzing the intrinsic GTPase 
activity of Rho GTPases to stimulate the hydrolysis of GTP to GDP (Figure 4). Finally, 
guanine disassociation inhibitors (GDIs) bind GDP-bound Rho GTPase and hold it in an 
inactive state away from the membrane, the normal site of Rho GTPase activity [28]. 
 
Figure 4: The Rho GTPase cycle. Rho GTPases are regulated by GEFs, GAPs and GDIs. 
Rho GTPase is activated by the exchange of GDP for GTP by GEFs. Conversely, Rho GTPases 
are negatively regulated by the catalysis of the hydrolyzing ability of GTPases by GAPs. GDI proteins bind 
GDP-bound RhoGTPase and retain it in an inactive state [28]. 
 
RhoGEF2 activates RhoA GTPase which stimulates downstream effector kinases 
such as Rho-kinase (Drok) (Figure 5). Rho-kinase phosphorylates myosin light chain 
kinase and inactivates myosin light chain phosphatase an enzyme which inhibits myosin 
light chain (Sqh) [38]. Phosphorylation of myosin light chain by myosin light chain 
kinase and Drok leads to activation of Sqh which in turn activates the myosin II heavy 
chain (Zipper) [39]. Activation of Zipper creates tension producing activity resulting in 
the contraction of the actin cytoskeleton. Rho-kinase also activates LIM kinase which 
phosphorylates and deactivates cofilin. Cofilin is normally dephosporylated and 
maintained in an activated state by cofilin phosphatase [40]. Thus, the deactivation of 
cofilin and the activation of myosin II heavy chain allows for F-actin polymerization, 
cytoskeletal reorganization and contraction. The LIM kinase pathway also results in the 
nuclear localization of serum response factor and induced transcription (Figure 5). 
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Figure 5: Model of RhoA mediated signaling in imaginal discs.  
(see text for discussion). 
 
The downstream activity of the RhoA pathway in the control of cell shape change 
in leg development is generally understood, however, the initial activation of RhoA 
signaling as well as the interaction between hormonal and intracellular signals driving leg 
disc development has not been fully elucidated. Because leg imaginal disc morphogenesis 
is absolutely dependent upon hormonal signaling at the onset of pupariation and RhoA 
signaling occurs in most if not all tissues, it has been proposed that ecdysone may 
temporally regulate RhoA signaling and cell shape changes in developing leg imaginal 
discs [12]. Other developmental systems also utilize hormonal activation of intracellular 
signaling pathways. An example is that of mammary development in mammals. In the 
development of this tissue, estrogen and thryrotropin hormone have each been reported to 
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activate epidermal growth factor receptor and subsequent downstream effectors via a G-
protein-coupled receptor mediated process during ductal morphogenesis in murine 
mammary tissue [41, 42]. 
Stubble serine protease and a proposed regulatory model 
One possible mechanistic link between the ecdysone hormone response and RhoA 
signaling is the trypsin-like type II transmembrane serine protease (TTSP) Stubble, 
encoded by the Stubble-stubbloid (Sb-sbd) gene. The TTSP family is characterized by a 
short N-terminal intracellular domain, a transmembrane domain, followed by a variable 
stem region which includes a cysteine knot in Stubble, and a C-terminal extracellular 














Figure 6: Structure of the Drosophila type II transmembrane serine protease.  
(see text for discussion). 
 
There are currently 15 vertebrate and one Drosophila TTSPs described. Many of 
the vertebrate TTSPs have been associated with various human pathologies including 
colon and breast cancers, renal carcinomas and ovarian cancer [43]. One TTSP in 
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humans, the transmembrane protease serine 2 (TMPRSS2) and is regulated by androgenic 
hormones and has been shown to be proteolytically auto-activated [44]. Although its 
biological functions have not been determined it has been shown that TMPRSS2 is highly 
expressed in the epithelium of the human prostate gland and has been implicated in 
prostate carcinogenesis [45]. 
The Stubble mutant is characterized by its shortened bristle phenotype later 
attributed to the disorganization of actin bundling [46]. Mutations in this locus also 
exhibit leg and wing malformations [12, 19, 22]. Stubble is induced rapidly after 
exposure to ecdysone and is essential for cell shape changes during leg morphogenesis. 
Sb-sbd mutants interact genetically with several RhoA pathway mutants such as RhoA, 
DRhoGEF2, drok, zipper, myosin phosphatase, cofilin phosphatase, and blistered/dSRF 
to cause malformed legs (Figure 4) and genetic analysis indicates that Stubble acts 
upstream of RhoA [12]. 
Based on this evidence, a model has been proposed in which temporally and 
spatially regulated induction of Stubble by ecdysone results in temporally and spatially 
restricted activation of RhoA, and reorganization of the actin cytoskeleton leading to leg 
epithelial morphogenesis (Figure 7; [12]). In this model, two possible mechanisms by 
which Stubble might activate RhoA are proposed. First, in a mechanism similar to that 
demonstrated in TMPRSS2 signaling, proteolytic activation of Stubble could lead to the 
activation of a Rho-guanine exchange factor (RhoGEF) via the Stubble intracellular 
domain (Figure 7). Second, Stubble might cleave an extracellular molecule such as a 
membrane associated receptor leading to activation of RhoA. This mechanism has been 
demonstrated also in TMPRSS2 intracellular signaling via proteolytic activation of the G-
protein-coupled receptor PAR2 in the development of the prostate gland [45]. Moreover, 
trypsin activates a proteolytically activated receptor (PAR) and Stubble is a member of 
the trypsin family providing further correlative evidence of the potential for Stubble to 
play a role in the proteolytic activation of intracellular signaling [47]. An additional mode 
of regulation of Stubble may be accomplished via serine protease inhibitors (Serpins). 
Serpins constitute a large family of proteins found in viruses, plants and animals and 
function as suicide substrate inhibitors which bind serine proteases and are themselves 
cleaved in the process of inhibiting target serine proteases. 
   
Figure 7: Proposed mechanisms regulating the activation of RhoA in imaginal discs: 
Stubble, an ecdysone responsive serine protease, activates RhoA via the Stubble intracellular 
domain (1). Activation of RhoA could also result from Stubble mediated cleavage of an associated 
membrane bound receptor (2). 
Genes involved in leg morphogenesis identified in a genetic screen 
In order to better understand the relationship between ecdysone and RhoA 
signaling during leg development a genetic screen for mutants that interact with Stubble, 
RhoA, and zipper mutations was conducted (see below). Six mutants were identified, 
three of which are new alleles of RhoA, DRhoGEF2, and zipper. The remaining three 
mutations, designated 18-5, 12-5, and 31-6, are all located on the second chromosome 
and fully complement other mutations in second chromosome genes known to be 
associated with ecdysone and RhoA signaling [12]. Therefore, they represent potentially 
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new genes involved in leg epithelial morphogenesis and their characterization may 
improve our understanding of the mechanisms governing the intersection between 
ecdysone and RhoA signaling in developing leg epithelia. The 18-5 and 12-5 mutations 
are pupal lethals while the 31-6 mutation is semi-lethal with death occurring 
predominantly during pupal development (Callis and von Kalm unpublished data). 
As a first step toward identifying the 18-5, 12-5, and 31-6 loci, preliminary 
genetic mapping studies were performed. Preliminary mapping of the 18-5 gene was 
performed using a combination of classical meiotic and deletion mapping. Both 
approaches gave consistent results placing the 18-5 gene in the 55D-E cytogenetic region 
of the second chromosome which provided a starting point for further work to identify 
the gene. Deletion mapping failed to reveal the chromosomal location of the 12-5 and 31-
6 genes. Because the 18-5 and 12-5 mutations exhibit more robust genetic interactions 
with Stubble and RhoA than 31-6 (Table 1; [12]), and 18-5 is already mapped to a 
relatively small chromosomal region, 18-5 and 12-5 are the primary foci of this thesis.  
Collective preliminary data describing the interactions of the 18-5 mutant strongly 
indicate a role for the 18-5 gene product in the interaction of the hormone activated 
Stubble serine protease and the RhoA signaling pathway during leg morphogenesis 
(Table 3; [12]). Bayer et al., (2003) observed robust genetic interactions between 18-5 
and 12-5 with Stubble and members of the RhoA pathway. Therefore, considering the 
strength of the genetic interactions of the 18-5 and 12-5 mutations with Stubble and 
members of the RhoA pathway in developing leg imaginal discs; identification and 
characterization of the genes encoding the 18-5 and 12-5 mutations is likely to better our 
understanding of the mechanistic relationship between the RhoA pathway and ecdysone 
hierarchy. 
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Aims of this thesis 
Extensive studies conducted by our lab and others have revealed that ecdysone 
mediated and RhoA mediated pathways act in a coordinated effort to regulated imaginal 
disc morphogenesis [11, 12, 48, 49]. The goal of this research is to identify and 
characterize the 18-5 and 12-5 genes in order to discern the mechanistic relationship 
between the RhoA pathway and ecdysone hierarchy. The major findings of the work are 
as follows: 
1.  I mapped the 18-5 and 12-5 genes to precise molecular locations within the 
Drosophila genome utilizing a P-element recombination mapping technique. This work 
narrowed the location of the 18-5 locus to within an interval of 112 kb within the 
Drosophila genome sequence. This interval contains 17 known and predicted genes. I 
also mapped the location of 12-5 to a 2.6 Mb interval of the 2nd chromosome. 
2.  Based on phenotypic analyses, a candidate gene for the 18-5 mutation was 
identified. Sequence analysis of the candidate gene in 18-5 homozygotes was 
inconclusive and requires further analysis. 
3.  Genetic interaction assays indicate that the 18-5 and 12-5 mutations interact 
with mutations in LIM kinase, Cdc42, and Egfr. 
4.  A third site suppression analysis was utilized to try to position 18-5 in the 
RhoA signaling pathway (Figure 5). Collectively these data place the 18-5 gene product 
at the level of or upstream of Rho kinase. 
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MATERIALS AND METHODS 
Drosophila crosses 
Standard Drosophila crosses were conducted as follows unless specifically noted 
otherwise. Drosophila crosses were set up with 4-6 virgin females and 4-5 two-five day 
old males in individual vials containing standard cornmeal medium. The adult flies were 
allowed to mate at 25°C for four days, at which time, the adults were transferred to a new 
vial of medium. The adults were transferred to a third vial on the seventh day following 
the initial cross resulting in three total vials from which F1 progeny emerged. Upon day 
ten of the mating cross, the adult flies were anesthetized and placed into a container of 
mineral oil. 
Standard bottle crosses were conducted as follows unless otherwise noted. Flies 
were set up in crosses of 30 virgin females and 15 two-five day old males in bottles of 
standard laboratory cornmeal medium. The flies were allowed to mate and lay eggs for 
four days and subsequently transferred to a fresh bottle. They were again transferred to 
fresh bottles on day seven and then the animals were euthanized on day ten. The strategy 







Deficiency mapping of 18-5 and 12-5 
Deletion mapping was conducted by complementation crosses between 18-5 or 
12-5 mutants and flies carrying deletions of the region near 55D-E of the second 
chromosome. The deficiency mapping was conducted in standard vial crosses. The 
resultant mutant/deficiency F1 flies were scored for reduced viability relative to sibling 
classes and leg and wing malformation  
Molecular mapping of 18-5 and 12-5 
In order to molecularly map the 18-5 and 12-5 genes, a P-element recombination 
mapping technique was utilized [50]. Briefly, this method entails determining the 
recombination distance between a mutation and P-element insertions to the left and right 
of a mutation. All P-element insertions used have been molecularly mapped to the 
Drosophila genome sequence. This technique permits the calculation of a nucleotide 
position between the P-elements corresponding to the location of the desired gene on the 
Drosophila genome sequence. 
Molecular mapping of the 18-5 mutation: 
The P-element recombination mapping technique entails three total crosses 
(Figure 8). First, the P1 cross was performed to obtain the necessary females carrying the 
P-element and desired mutation in a trans-heterozygous condition (i.e. P, +/+, 18-5). The 
P1 cross was conducted in a standard bottle cross. 
 
Figure 8: This schematic explains the crossing scheme used to conduct the P-element 
recombination mapping. 
The mapping scheme was adopted for both 18-5 and 12-5 mapping and is shown for the 18-5 
mutation. The females carrying both the mutation and the P-element are generated in the first cross. 
Following recombination in the F1 females, recombinants were distinguished from non-recombinants in the 
F2 cross (see text for discussion). *CyH is a 2nd chromosomal balancer carrying aGMR-Hepsin transgene. 
Hepsin is a vertebrate type II transmembrane serine protease and GMR is an eye specific promoter [60]. 
**CR2 is a 2nd chromosomal balancer which carries a sev-Ras transgene. Ras is a GTPase and sevenless is 
an eye specific promoter. 
 
Recombination occurs in the F1 females which were crossed to 18-
5/Curly:Hepsin (CyH) males. The F1 cross was done in a set of 100 separate standard 
vial crosses, but altered by using 10 virgin females to increase the density of the 
offspring. An additional change to the standard crossing scheme included culturing F1 
animals for 4 days at 25°C and then transfer to 18°C so that all white eyed F2 females 
could be recovered and crossed as virgins in the third recombination mapping cross. 
Approximately 95% of 18-5 homozygotes are either unable to eclose or exhibit 
severe wing and leg malformation. However, up to 5% of 18-5 homozygotes “escapers” 
do not exhibit any malformation phenotype and appear to be wildtype. This is significant 
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in that phenotypically wildtype 18-5, +/+, 18-5 non-recombinants would be scored as 
recombinants, thus influencing the molecular mapping calculations. In order to 
distinguish the true recombinant  +, +/+, 18-5 animals from the non-recombinant 
escapers, we tested all F2 white eyed flies to determine if they were recombinants (Figure 
9). 
All F2 generation white eyed flies were collected as virgins and mated 
individually to 4-5 virgin female or two to five day old male 18-5/CR2 animals. In this 
cross, the homozygous 18-5 escapers produced either animals carrying the CR2 balancer 
or 18-5 homozygotes (Figure 9). However, if the white eyed fly is a recombinant (i.e.  
+/18-5), then the resultant progeny contains an additional class of 18-5 heterozygotes 
which appear wildtype. This provides a ratio from which we can determine which 
animals are true recombinants. The non-recombinant progeny result in a ratio of 
approximately two curly wing/rough eyed animals to zero wildtype animals. Conversely, 
the F2 recombinants crossed to 18-5/CR2 produce a ratio of approximately two curly 
wing/rough eyed progeny to one wildtype class (Figure 9). A set of stringent criteria were 
designed for the analysis of F2 crosses in which the results were ambiguous. 
1. In order for the F2 progeny to be scored, the CR2 class must have more than 
20 animals. If the CR2 class contains less than 20 animals, the data is 
excluded from the final calculations. 
2. In order for the F2 animal to be deemed a non-recombinant, the CR2/WT ratio 
must be >4.00 and malformation frequency must be >30% unless the number 
of animals with wildtype eyes is < or = 3.00 or the CR2/WT ratio > 5.00. 
However, for CR2/WT ratios that are between 3.00 and 4.00, the total 
malformation must be >50% 
3. To be classified as a recombinant: CR2/WT must be <4.00 and mlf must be 
<50% 
In this manner, I was able to determine which F2 white eyed fly was a 
recombinant due to the much greater number of observed wildtype progeny arising from 
the F2 recombinant compared to those resulting from the non-recombinant cross. 
 
Figure 9: Strategy for distinguishing white eye F2 non-recombinants from the F2 recombinants. 
Molecular mapping of the 12-5 mutation 
Molecular mapping of 12-5 was conducted using the P-element recombination 
technique described above, but with key modifications to the strategy. First, the crosses 
were conducted entirely in bottles of 30 virgin females and 10-15 two-five day old males 
and the work was performed entirely at 25°C. Second, because the distances between the 
P-elements and 12-5 were for the most part very large, and because the frequency of 12-5 
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homozygote escapers is very low, all F2 white eyed animals were considered to be 
recombinants. Initial mapping experiments were conducted utilizing a 2nd chromosome 
rough mapping P-element mapping kit. The P-element mapping kit is a set of molecularly 
defined P-elements specified by the Bellen lab at the University of Baylor and is 
available from the Bloomington stock center at the University of Indiana. The insertions 
are located at regular intervals along the 2nd and 3rd chromosomes and can be utilized for 
P-element recombination mapping [50]. 
18-5 suppression analysis 
Suppression of the 18-5 malformation phenotype was analyzed as described in 
Figure 10. The frequency of leg and wing malformations and ectopic crossveins was 
compared in RhoA, 18-5, Mbs or ssh and RhoA, 18-5, TM2 triple mutants. These crosses 
were set up in sets of 5 vials of 6 virgin female 18-5/CyO,GFP; +/+ and 4-6 two-five day 
old males carrying either Mbs3 or ssh. The flies were allowed to breed and lay eggs on 
standard cornmeal medium for four days at 25°C. The adults were transferred to new 
vials in order to continue egg laying on the 4th and 7th day post-P1 cross. This crossing 
strategy provided a total of 15 vials per cross. The adults were then euthanized on day 
ten. 
 
Figure 10: Representative schematic of the suppression analysis crosses. 
Image depicts a cross for 18-5 in which the triple mutant for RhoA, 18-5 and Mbs are scored and 
compared to the Rho/18-5 mutant lacking the Mbs mutation. Similar experiments were also conducted for 
ssh. Only two of the possible F1 progeny classes are shown. 
 
Sequencing of DRal GEFmeso 
Extraction of genomic DNA: The 18-5 mutation was rebalanced over CyO 
carrying an enhanced yellow fluorescent protein (EYFP). This EYFP is under the control 
of the Deformed promoter. Under these conditions, EYFP is strongly expressed in the 
mouthparts and spiracles of Drosophila larvae.  
Two sets of 20 wandering 3rd instar 18-5 or 12-5 (as progenitor controls) 
homozygous larvae were collected based on the lack of EYFP expression. The larvae 
were placed into 1.5 mL microcentrifuge tubes, snap frozen in liquid nitrogen and stored 
at -80°C. The larvae were homogenized with a motorized pestle in 250 uL of 
homogenizing buffer (100 mM Tris-Cl pH 9.1, 50 mM EDTA, 100 mM NaCl, 200 mM 
sucrose and 0.5% SDS). After the larvae were completely homogenized, 250 uL of 
phenol and 250 uL chloroform were added and the mixture was spun at 14,000 rpm for 5 
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minutes at 4°C in an Eppendorf microfuge. The aqueous phase was placed into a new 1.5 
mL centrifuge tube and the step was repeated. 
Next, the addition of 500 uL of cold 100% ethanol precipitated the DNA and 
centrifugation pelleted the sample. The pelleted DNA was precipitated again with 500 uL 
of cold 100% ethanol and pelleted at 14,000 rpm for 5 minutes. Finally, the pellet was 
washed with 70% ethanol. The pellet was dried in a vacuum centrifuge and resuspended 
in 25 ul TE +RNase (0.5ul of 100mg/ml RNase to 25 mL TE). 
PCR amplification of GEFmeso: GEFmeso was PCR amplified from 18-5 and 
12-5 homozygotes with the use of 12 sets of primers to amplify separate small 
overlapping amplifications of approximately 500-700 base pairs in length including the 
entire coding region (Table 2). 
Table 1: Primers used for the PCR amplification of GEFmeso. 
 Primer Name Sequence Fragment size 
 Exon1 Forward  CATGTAGACTTTAGATAACAGCGCTG 
 Exon1 Reverse  CCATGTGGATTACGCTGATCCC 
741 
 Exon2 Forward  GTTGTCATCGCTGTAAATGGCCG 
 Exon2 Reverse  CATGTGCCCTACAAATTCTCACCG 
 662 
 Exon3 Forward  TTCGGGCGAGTAGACTAGGG 
 Exon3 Reverse  CACAAGACGATGCCCAAAAGATAGCC 
 611 
 Exon4 Forward  TTCCGTCTCGTGATCTGGGC 
 Exon4 Reverse  CTGCCGGAGGAGTGAGATACGC 
 765 
 Exon5 Forward  TCTTCGCTCCCTCCTTCACTGC 
 Exon5 Reverse  TGCTAGCTTTAATTGGCCTTCTAACACG 
 560 
 Exon6 Forward  CCGCATGTGCATAACTGTTAGGC 
 Exon6 Reverse  GCCAGGTAAGTGTGGGAGC 
 675 
 Exon7 Forward  ATGATCAGCATGGTGGCGAATAGC 
 Exon7 Reverse  CACACGTACTCTCTGCTTGCCTCC 
 451 
 Exon8 Forward  CACCCAGAATACTAACTAGGTCAGG 
 Exon8 Reverse  GAAAGTCTGGACAGGCTCACCG 
 675 
 Exon9 Forward  CTCTCCGCCAGACTTTCTACGC 
 Exon9 Reverse  GAACAAATCGGTACCAGGCACTCC 
 705 
 Exon10 Forward  ATGCTCTGCTGTGAATCGTACCG 
 Exon10 Reverse  ATGACCAGTCTGCTAGCTACACG 
 617 
 Exon11 Forward  TCAACTGAGCGCCATCCG 
 Exon11 Reverse  ATCAACATTGCAGCACCTCGGTCG 
 620 
 Exon12 Forward  CGTGAGATGTCGCAGTGGGAGC 




Amplification of two large introns was omitted; however, intronic regions close to 
exons were included to test for possible splice site mutations. The amplification was run 
with two thermocycle programs settings. Amplification of eleven of the twelve reactions 
was conducted with an annealing temperature of 55°C, while an annealing temperature of 
56°C was found to be optimal for exon 11 (Table 3). 
Table 2: Thermocycler settings for the PCR amplification of GEFmeso. 
  55°C     56°C   
Sample Step 
Temp. 
(in °C) Time Sample Step 
Temp. 
(in °C) Time 
Exon 1     Exon 11      
Exon 2 Denaturation 95 :30   Denaturation 95 :30 
Exon 3 Annealing 55 :30   Annealing 56 :30 
Exon 4 Extention 72 :45   Extention 72 :30 
Exon 5 Cycle numbers 35x    Cycle numbers 35x   
Exon 6 Final Extention 72 7:00   Final Extention 72 7:00 
Exon 7 Stop 4 **   Stop 4 ** 
Exon 8            
Exon 9            
Exon 10            
Exon 12               
 
The PCR mixture conditions were constant for all runs (1x buffer, 0.5 uM forward 
and reverse primers, 0.8 mM dNTPs, 2.0 mM MgCl2 .1 uL/reaction DMSO, 1 U Sigma 
Taq polymerase and 1uL DNA sample). The PCR products were separated on a 0.8% 
agarose gel with ethidium bromide (20 ul ethidium bromide to 100 mL agarose gel) for 
1.5 hours at 60 volts. 
Each gel band containing the desired PCR product was excised from the agarose 
gel. The agarose gel containing the PCR product was weighed and incubated with three 
volumes of NaI solution at 50°C for five minutes. Next, 5 uL of Geneclean aqueous silica 
gel suspension (Qbiogene) was added and the sample was incubated at room temperature 
for 10 minutes with intermittent mixing. The silica gel/DNA mixture was pelleted by 
centrifugation for one minute at 14,000 rpm. The pellet was washed with “new wash” 
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(Tris-amiomethane, Qbiogene) and centrifuged for one minute at high speed. The pellet 
was washed two additional times and dried in a vacuum centrifuge for 15 minutes. 
Finally, the pelleted silica gel/DNA mixture was washed in 15 uL of purified water and 
10 ul of the purified DNA was transferred to a new 1.5 mL microcentrifuge tube. 
Cloning: 3.5 uL of each purified PCR product was transferred into a clean 1.5 mL 
tube followed by the addition of 1.2 ul of salt solution (1.2 M NaCl, 0.06 M MgCl2) and 4 
ng of plasmid vector pCRII-TOPO (Invitrogen). The mixture was incubated at room 
temperature for five minutes, then 37°C for ten minutes and transferred to ice. Next, 18 ul 
of Oneshot TOP10 chemically competent E. coli (Invitrogen) was added and incubated 
for ten minutes before heat shock treatment at 42°C for 30 seconds. This was 
immediately followed by the addition of SOC medium (Invitrogen) and shaken at 250 
rpm at 37°C for 70 minutes. The cells were then plated onto kanamycin/Xgal plates (50 
ug/mL kanamycin, 60 ug/mL Xgal). The colonies were then grown at 37°C overnight and 
then placed at 4°C. 
Next, white colonies of each plasmid transformation were collected and incubated 
in LB broth with ampicilin (50 ug/mL) at 37°C at 250 rpm overnight. The cells were 
pelleted at 14,000 rpm for four minutes and then the plasmid DNA was prepared using a 
Qiagen Plasmid DNA miniprep kit. Finally, the plasmid DNA was quantified on a 
Nanodrop spectrophotometer. 
Sequencing: Samples were sequenced at the Interdisciplinary Center for 
Biotechnology Research facility at the University of Florida. Sample aliquots were 
sequenced with the forward and reverse M13 primers using an automated sequencer 
(Perkin Elmer/Applied Biosystems). 
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RESULTS 
Preliminary genetic interaction data 
Preliminary genetic interaction data conducted by Bayer et al., (2003), indicates a 
possible role for the 18-5 and 12-5 gene products within the RhoA signaling hierarchy 
regulating leg development. The 18-5 mutant exhibits moderate (25-49%) leg 
malformation with zipper and Stubble (Table 3). It also interacts strongly (>50%) with 
RhoA alleles and Df(2R)Jp8, a deficiency that uncovers RhoA. Additionally, 18-5 exhibits 
a moderate interaction with 31-6, a strong interaction with 12-5, and is lethal when 
expressed as a homozygote (Table 3). Similarly, genetic data for 12-5 showed that 12-5 
also interacts strongly with RhoA and zipEbr mutants and weakly to moderately with 
various Stubble alleles (Table 3). 
 
Table 3: 18-5 and 12-5 genetic interactions with ecdysone activated Stubble and members of the 
RhoA signaling pathway regulating leg morphogenesis. 
All animals are doubly heterozygous for the alleles indicated. The numbers shown indicate the 
percentage of animals with malformed legs with the total number of animals scored shown in parentheses. 
Reduced viability of 12-5, +/+, 18-5 compared to sibling classes indicated by an * [12]. 
18-5 and 12-5 genetic interactions 
 18-5/+ 12-5/+ 
Sb6.3b/+ 34 (388) 17 (229) 
Sb70/+ 37 (299) 39 (257) 
RhoAJ3.8/+ 81 (193) 94 (148) 
RhoAE3.10/+ 75 (275) 93 (125) 
Df(2R)Jp8/+ 72 (281) 78 (209) 
zipEbr/+ 41 (311) 71 (186) 
12-5/+ 89 (85)* Lethal 
18-5/+ Lethal 89 (85) 
31-6/+ 35 (249) 37 (259) 
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Deficiency mapping of 18-5 
Deficiency mapping localizes the 18-5 gene to 55D2-55E2.  Previous deficiency 
mapping placed the 18-5 gene in the 55DE cytogenetic region (Callis and von Kalm, 
unpublished data). This region is 255 kb and contains 58 known and predicted genes. In 
order to identify potential 18-5 candidate genes, higher resolution mapping of the 18-5 
mutation was conducted. 
Deletion mapping, a technique utilizing deficiencies or regions in which the DNA 
is deleted, was conducted to further refine the region containing the 18-5 gene. This was 
accomplished by complementation tests between deficiencies and the 18-5 mutation. 
Those deficiencies which exhibit lethality, reduced viability and/or a high frequency of 
leg malformation are strong candidates to delete the region in which the 18-5 gene is 
located. Previous mapping using deficiency, Df(2R)Pu66 narrowed the left boundary to 
the 55D2 region while the right boundary of Df(2R)Pu66 remained unclear and defined 
as between 55E1 and 56B2. To better define the cytogenetic region containing the 18-5 
locus, three additional deficiencies were used to more precisely define the right boundary 
of Df(2R)Pu66 (Table 4; Figure 11). 
Table 4: This table indicates the results of the complementation tests conducted to more precisely 
define the right boundary of Df(2R)Pu66. 
Those deficiencies that complement are noted by a +, while those that fail to complement are 






region 18-5 Df(2R)Pu66 Df(2R)PC4 
w1118; Df(2R)Exel7158, 
P+PBac{XP5.WH5}Exel7158/CyO 7895 55E2-55E10 + + - 
w1118; Df(2R)Exel7157, 
P+PBac{XP5.RB3}Exel7157/CyO 7894 55E7-55F6 + + - 
W1118; Df(2R)Exel6067, P{XP-
U}Exel6067/CyO 7549 55F8-56A2 + ND ND 
For simplicity during all further discussion Bloomington stock numbers will be 
used. Ex7895 overlaps with Df(2R)PC4, but does not overlap with Df(2R)Pu66 (Figure 
11). Similarly, Ex7894 deletes a region to the right of the region deleted by Df(2R)Pu66, 
and overlaps with Df(2R)PC4. Furthermore, the deficiencies in table 4 complement the 
18-5 mutation, indicating that the mutation is located outside of the boundaries defined 
by these deficiencies. 
The left boundary of Ex7895 is 55E2 and the right boundary of Df(2R)Pu66 has 
been previously defined as 55E1-56B2. Therefore, the complementation of Ex7895 and 
Df(2R)Pu66 defines the right boundary of Df(2R)Pu66 as 55E1-2. Thus, the 18-5 
mutation is located between 55D2 and 55E1-2. 
 
Figure 11: Image depicting the deficiency mapping of 18-5. 
The cytogenetic region is listed above the map. The green bar at the bottom represents the 2nd 
chromosome. White bars indicate deleted regions that complement 18-5 while those in red do not 
complement 18-5. 
 
Many of the breakpoints of Drosophila deficiencies are not well defined, so I 
therefore conducted additional experiments to confirm the left and right breakpoints of 
Df(2R)Pu66. I used molecularly defined P-element insertions to further map the 
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deficiency breakpoints. If a lethal molecularly defined P-element insertion is located 
within the deletion, then the animal carrying both the P-element and deficiency will die, 
however, if the P-element is outside the deleted region the animal will survive and the 
molecular position of the P-element will help to define the endpoint of the Pu66 
deficiency. Five molecularly defined lethal P-elements were tested (Table 5; Figure 12).  
 
Table 5: Lethal P-element insertions used to better define the breakpoints of the deficiency, 
Df(2R)Pu66. 
The P-element insertions were tested for complementation with deficiency Df(2R)Pu66 and were 
tested with the much larger deficiency, Df(2R)PC4, to verify the lethality of the P-element insertion. The P-
element insertions that complement the deficiencies are represented by +, whereas those that fail to 
complement are represented by -. (* Semi-lethal P-element insertions in which the complementation data is 
inconclusive) 




Location Df(2R)Pu66/CR2 Df(2R)PC4/CR2 
Pbac{w[+mC]=RB}CG5189[e01140]/
CyO 17928 55C9 + - 
P{SUPor-P}CG5226/CyO 13949 55D1 + - 
P{SUPor-P}KG08199/CyO 15126 55E2 +* +* 
P{SUPor-P}KG04591/CyO 14100 55E6 + - 
y1,w67c23; P{lacW}edlK06602/CyO 10633 55E6 +* +* 
 
I will use a nomenclature describing the cytological location of each P-element 
for simplification purposes. Transgene insertions P(55C9) and P(55D1) were fully viable 
over deficiency Df(2R)Pu66 but were lethal over Df(2R)PC4 (Table 5). This indicates 
that the left boundary of Df(2R)Pu66 must be to the right of 55D1 and indicates that the 
published cytogenetic boundary of the left side of Df(2R)Pu66 is correct. 
P-elements P(55E2) and P(55E6) complemented deficiencies Df(2R)Pu66 and 
Df(2R)PC4. The molecular position of P(55E2) and P(55E6) are known to be located 
within the breakpoints of the large deficiency Df(2R)PC4. Therefore, since the P-
elements are viable over Df(2R)PC4, this suggests that P(55E2) and P(55E6) are semi-
lethal insertions and the data obtained from the respective crosses with Df(2R)Pu66 are 
inconclusive. P-element P(55E6) is lethal over Df(2R)PC4, but viable when crossed to 
deficiency Df(2R)Pu66. The molecular position of P-element 14100 is 55E6. This 
confirms the deletion mapping conducted with deficiency Ex7895 discussed above in 
which the right boundary of Df(2R)Pu66 was defined as 55E1-2. 
Through this deletion mapping, the region in which the 18-5 locus is located was 
further refined to a location between 55D2 and 55E2 (Figure 12). This 140 kb region 
contains a total of 32 known and predicted genes and therefore further mapping was 
required in order to reduce the number of candidate genes.  
 
 
Figure 12: Image depicting the P-element insertions used to further define the boundaries of the 
deficiency Df(2R)Pu66 used to map 18-5. 
Transgene insertions 17928 and 13949 (blue stars) define the upstream boundary of Df(2R)Pu66 
while the lethal insertion, 14100 defines the downstream boundary. The P-elements numbered 15126 and 
10633 (yellow stars) are semi-lethal. 
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Molecular mapping of the 18-5 gene 
Molecular mapping defines the location of the 18-5 gene to within a 112 kb 
interval of the Drosophila genome.  More precise mapping of the 18-5 gene represents a 
necessary step toward cloning and gene characterization. To map the 18-5 gene to a more 
precise location, I utilized a recently published mapping technique that permits molecular 
mapping of a gene on the published genome sequence [50]. This technique has been 
shown to be accurate to within 50kb and frequently allows identification of the gene 
itself. In this approach, mutations are mapped relative to P-element transposons with 
insertion points that have been molecularly defined in the Drosophila genome sequence. 
To calculate the precise molecular location of the desired gene, the technique utilizes P-
element insertions located to the left and right of the gene of interest (Figure 13). 
Recombination rates between P-elements positioned to the left and right of the desired 
mutation and the mutation are used to determine a precise molecular position on the 
genome sequence (Figure 13). 
An additional benefit of mapping with P-elements is that several thousand P-
element insertions have been mapped to a molecular position in the Drosophila genome. 
This allows P-elements close to the mutation of interest to be selected which greatly 
improves the accuracy of the technique. 
  
Figure 13: Schematic depicting the P-element recombination mapping technique.  
The known molecular distance (a) between two P-elements (triangles) located to the left and right 
of the mutation (asterisk) is utilized to convert the recombination distances between the P-elements and the 
mutation into molecular distances between the P-elements and the mutation (b and c). The molecular 
distances b and c are used to calculate the precise molecular position of the mutation. 
 
The P-element/18-5 recombination distances were calculated for three P-elements 
to the left of 18-5 and one P-element to the right of the mutation (Table 6). Two P-
element insertions referred to as 12921 and 17538 are located less than 800 kb to the left 
of the center of Df(2R)Pu66 while 14517 is less than 300 kb to the right of the center of 
Df(2R)Pu66 (Table 6). P-element 16573 is located a distance of 3,076 kb to the left of the 
center of Df(2R)Pu66. The recombination rates between the P-element insertions and 18-
5 shown in table 6 and Figure 15 have been calculated in centimorgan units. These 
recombination distances were utilized in the calculation (see below) of the precise 







Table 6: 18-5/P-element recombination data used to calculate the molecular position of the 18-5 
locus. 
Three P-element insertions are located to the left of Df(2R)Pu66 while one insertion is located to 
the right of Df(2R)Pu66. The distance from the P-element insertion to the center of Df(2R)Pu66 is 
indicated in kilobases. The recombination distance (RD) between each insertion and the 18-5 mutaion is 







Distance from center 
of Df(2R)Pu66      
(in kb) 
18-5/P-element recombination 
distance in centimorgans.     
(total w- and w+ animals scored) 
Left of 18-5     
w1118; P{EPgy2}EY03741/ 
CyO, P{sevRas1.V12}FK1 16573 11,027,098 3,076 8.6 (1188) 
y1 w67c23; P{SUPor-
P}KG00600 12921 13,307,435 798 1.9 (1070) 
y1 w67c23; P{EPgy2} 
olf186-FEY9167 /In(2L)Gla 17538 13,370,071 796 1.8 (1941) 
Right of 18-5     
y1 w67c23; P{SUPor-
P}KG07142 14517 14,350,084 297 1.2 (3063) 
 
Calculations:  The calculation of the molecular position consists of three general 
steps. First, the recombination distances (RD) between the P-elements and the mutation 
of interest must be determined in centimorgan units. Second, the RD is then converted 
into a projected molecular distance (PMD) measured in base pairs (Figure 14). Third, the 
PMD is subsequently added to the nucleotide position of the upstream P-element to 
obtain the projected molecular position (PMP) of the gene. 
The molecular distance between two P-elements located to the left and right of 
18-5 was calculated and divided by the sum of the recombination distances (in cM units) 
between each P-element and the mutation. This number (bp/cM) was multiplied by the 
distance in cM between the upstream P-element (P1 in figure 13) and 18-5. This projected 
molecular distance between P1 and the mutation (PMDb) was added to the known 
molecular position of P1 to get the projected molecular position (PMP) of 18-5 within the 
Drosophila genome sequence. This procedure was repeated for various P-elements in the 
mapping of 18-5. 
   
Figure 14: This figure shows the formula used to calculate the projected molecular position (PMP) 
of the 18-5 mutation.  
The projected molecular distance (PMDb) between the upstream P-element (P1 from figure 13) and 
the mutation is calculated by converting the recombination distances (RD b and c from figure 13, measured 
in centimorgans) of the upstream and downstream P-elements into a molecular distance (PMD) measured 
in base-pairs. The PMDb (distance from P1 to mutation) is added to the nucleotide position of the upstream 
P-element to identify the precise molecular position of the mutation. 
 
There are two caveats to acknowledge when utilizing this mapping procedure. 
The mutation must be a lethal mutation (i.e. homozygotes are inviable) and the P-
elements must be as close to the unknown locus as possible which improves the 
resolution of the recombination distances. If the mutation is semi-lethal, the homozygous 
mutant survivors will appear to be recombinants (see below), thus increasing the 
recombination frequency between the P-element and the mutation. Unfortunately, 18-5 
presents a complicated challenge because up to 5 % of homozygous animals live to 
adulthood. Therefore, in order to map the 18-5 locus, an additional cross (see methods) 
was performed to distinguish true F2 generation recombinants from the F2 non-
recombinant homozygous adults. 
The molecular mapping data for P-elements 16573, 12921, 17538, and 14517 
placed the 18-5 locus within a 37 kb region of the genomic sequence located 
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approximately 75 kb to the left of the left breakpoint of  Df(2R)Pu66, the smallest 
deficiency to uncover 18-5 (Table 6; Figure 15). Given that none of the P-elements tested 
on the left were closer than 800 kb to the center of Df(2R)Pu66, it is likely that mapping 
error associated with the distance between the P-elements on the right and Df(2R)Pu66 
accounts for the discrepancy in location of the 18-5 locus. However, the mapping data do 
suggest that 18-5 may be closer to the left end of Df(2R)Pu66. 
 
Figure 15: Image depicting the P-elements (triangles with dashes indicating their respective 
positions) used to map the 18-5 gene and the deficiencies defining the smallest mapped region in which the 
18-5 gene is located.  
The RD value for each 18-5/P-element cross is above each arrow (also noted in table 6). The 
mapping data calculated with the RD values places the 18-5 locus within a 37 kb region of the genome 
sequence located approximately 75 kb to the left of the left breakpoint of Pu66 (red portion of the 
chromosome). 
A closer view of the mapping region depicted in figure 16 below shows the 75 kb 
difference in the P-element recombination and deletion mapping techniques. Therefore, 
taken together, the entire region containing the 18-5 locus mapped using the deletion and 
P-element recombination mapping techniques represents a region of approximately 112 
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kb. This region contains 17 known or predicted genes as well as possible non-coding 
RNAs and siRNAs (Figure 16). 
 
Figure 16: Genomic region in which 18-5 was mapped.  
This image shows the three molecular positions of 18-5 mapped by P-element recombination as 
well as the deficiency Df(2R)Pu66 as a reference. Position 1 was calculated with P-elements 16573 and 
14517. Positions 2 and 3 were calculated with 12921 and 14517, and 17538 and 14517 respectively. This 
image represents the smallest region (approximately 112 kb) in which 18-5 is located. The resulting 
mapping region contains 17 known or predicted genes (blue bars) as well as many transgene insertions 
(triangles) useful for complementation testing with 18-5. 
Testing mutations and transgene insertions within the mapped region for 
complementation with 18-5 
18-5 complements all mutants and transgene insertions in genes available for 
testing in the 55D region.  The 18-5 gene was mapped to a region of approximately 112 
kb. I expanded this interval to a larger area containing 43 known and predicted genes to 
be certain not to exclude potential gene candidates. To investigate the possibility that one 
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of these 43 genes is allelic to the 18-5 mutation, I conducted complementation tests 
between all available mutant alleles and mobile element insertions in the region (table 7). 
 I complementation tested transgene insertions in 30 of the known or predicted 
genes within the region. Those genes which are located in the 112 kb mapped region are 
listed in bold in table 7. All of the mobile element insertions that were tested with 18-5 
were found to complement the mutation (Table 7). 
Table 7: Results of complementation tests between 18-5 and various transgene insertions within or 
close to the 112 kb region containing the 18-5 locus. 
Genotype of stock Gene of interest 
Bloomington 
stock number Outcome 
P{SUPor-P}l(2)55Db425-1/CyO l(2)55Db 4563 Complement 
b1 pr1 fs(2)PC4-U133 cn1bw1/CyO fs(2)PC4-U 6044 Complement 
y1 w*; P{lacW}A1-2-54 Ecol\lacZA1-2-54RA 10828 Complement 
P{PZ}Prp1907838 cn1/CyO; ry506 Prp19 12346 Complement 
P{PZ}l(2)0877008770 cn1/CyO; ry506 l(2) 08770 12357 Complement 
w1118; P{GT1}BG02569 Pepck 12815 Complement 
y1 w67c23; P{SUPor-P}KG01082 CG30122 13305 Complement 
y1 w67c23; P{SUPor-P}KG00319 CG30332 13650 Complement 
y1 w67c23; P{SUPor-P}KG01197 CG10927 13706 Complement 
y1 w67c23; P{SUPor-P}Eip55EKG02526 Eip55E 13752 Complement 
y1 w67c23; P{SUPor-P}KG04893 CG15092 13856 Complement 
y1 w67c23; P{SUPor-P}KG04987 CG30118 13863 Complement 
y1; P{SUPor-P}CG5226KG03347/CyO; ry506 CG5226 13949 Complement 
y1 w67c23; P{SUPor-P}CG5224KG05424 CG5224 14114 Complement 
y1 w67c23; P{EPgy2}EY00755a  CG10924 15473 Complement 
y1 w67c23; P{EPgy2}EY06260 CG5226 15962 Complement 
w1118; P{EP}SP2637EP2381 SP2637 17246 Complement 
y1 w67c23; P{EPgy2}EY07730 Slim 17396 Complement 
y1 w67c23; P{EPgy2}SP2637EY08074 SP2637 17427 Complement 
y1 w67c23; P{EPgy2}EY08359 CG10927 17454 Complement 
y1 w67c23; P{EPgy2}EY10175 CG30116 17645 Complement 
w1118; PBac{RB}CG33147e00779 CG33147 17884 Complement 
w1118; PBac{w[+mC]=RB}GstE7[e01100] GstE7 17923 Complement 
w1118; PBac{RB}mRpS28e02239/CyO MRpS28 18029 Complement 
w1118; PBac{RB}CG10924e03788 CG10924 18191 Complement 
w[1118]; PBac{w[+mC]=WH}imd[f02746] Imd 18583 Complement 
w1118; PBac{WH}CG18604f03280 CG18604 18634 Complement 
w1118; P{XP}Atg7d06996/CyO Atg7 19257 Complement 
w1118; P{XP}CG33147d07752 CG33147 19280 Complement 
y1 w67c23; P{EPgy2}CG5224EY08313 CG5225 19926 Complement 
 38
18-5 genetic interactions 
18-5 interacts genetically with 12-5, RhoA, Cdc42, Lim kinase and Egfr, but 
not with blistered, Ral GTPase, Ral-like protein, Ral guanine nucleotide exchange 
factor 2, or p21 activated kinase.  18-5 homozygotes exhibit leg and wing malformation 
phenotypes characteristic of mutations in genes of the RhoA signaling pathway as well as 
ecdysone activated Stubble mutants (Table 8). 18-5 homozygotes often exhibit the 
characteristic leg malformations represented by shortened, twisted femurs (67%). The 
wing of 18-5 homozygotes exhibits 81% overall malformation. The overall wing 
malformation can be further separated into general wing malformations including 
crumpled or blistered wings (50%) and wings expressing ectopic crossveins (31%).  
Standard vial crosses were conducted in order to better characterize the genetic 
interactions between mutant alleles of various genes and 18-5 (Table 8). Genetic 
interactions of 18-5 were analyzed with second-site non-complementation tests between 
18-5 and mutations in genes which are proposed to play a role in wing and/or leg 
development. Briefly, second-site non-complementation is defined as the crossing of two 
animals with genes at differing loci which results in trans-heterozygote offspring that 
exhibit the malformed phenotype typically observed in the homozygotes. Moreover, this 
non-complementation of two genes reflects a functional connection between differing 
gene products. 
The 18-5 ectopic crossvein phenotype is of interest to this study because 
mutations in genes such as18-5, RhoA, Sb, Lim kinase, Cdc42, and Rala have been shown 
to exhibit ectopic wing crossveins, thereby suggesting a possible functional relationship 
between the gene products (Table 8; [48, 51-53]). As heterozygotes, 18-5 mutants do not 
exhibit either leg or wing malformation. However, as trans-heterozygotes carrying 18-5, 
several genes were shown to interact genetically with 18-5 and exhibit leg and/or wing 
developmental malformations (Table 8). The genes which interact with 18-5 especially 
regarding crossvein development include; LIM kinase (8%), RhoA72O (19%), Cdc42 (9-
53%), and 12-5 (43%) (Table 8), moreover, these mutants do not exhibit ectopic 
crossveins as heterozygotes.  
The ectopic crossvein phenotype is important because it is expressed by mutations 
in genes such as RhoA, Sb and LimK which play a significant role in the morphogenesis 
of the leg and wing. The ectopic vein is most often seen between longitudinal veins three 
and four and between the anterior and posterior crossveins (Figure 17). The ectopic 
crossvein seen in figure 17 is the additional crossvein most often observed, although, 
there are often ectopic crossveins in other areas of the wing as well as additional 
crossveins which remain incomplete and do not reach across the intravein space. 
 
 
Figure 17: Wing malformation phenotype depicting the extra crossvein.  
The photo on the left is of a wildtype wing, note the anterior wing crossvein (AC left, small) and 
the posterior crossvein (PC right, wider). The image on the right is wing from a +, Cdc424; +/18-5 animal 
with an extra crossvein appearing between longitudinal veins three (L3) and four (L4) and between anterior 




Other genes were tested with 18-5 to investigate their prospective roles in wing 
vein development (Table 8). These include the genes; blistered (bs), Rala GTPase (Rala), 
Ral-guanine nucleotide exchange factor 2 (Rgl), and Ral-like protein (rlip). Interestingly, 
none of the trans-heterozygotes carrying one copy of 18-5 and one copy of the indicated 
allele exhibited any malformation including ectopic wing crossveins (Table 8). Blanke 
and Jackle (2006) showed that a dominant negative Ral GTPase under the control of an 
en-Gal4 driver resulted in additional but incomplete crossveins [53], but interestingly, the 
Rala mutants I tested with 18-5 did not exhibit any malformations as a trans-heterozygote 
with 18-5 (Table 8). 
Blanke and Jackle (2006) recently showed that RNAi knockdown of GEFmeso (a 
Ral guanine nucleotide exchange factor), resulted in the induction of additional 
crossveins. Similar ectopic crossveins in the wing are also exhibited in dominant negative 
and loss of function Cdc42 mutations and Lim kinase mutants [48, 51-53]). Significantly, 
GEFmeso is located within the mapped interval defining the location of the 18-5 gene 
(CG30115 in figure 16). 
Taken together, this genetic data, along with the location of GEFmeso within the 
mapped interval of 18-5, makes GEFmeso a realistic candidate for the location of the 18-
5 mutation locus. 
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Table 8: Genetic interactions of 18-5. 
All stocks shown were crossed to 18-5/CR2 and the trans-heterozygotes carrying the 18-5 
mutation and the mutation in the gene of interest were scored for leg and wing malformation. Numbers 
indicate the percent malformation observed in the trans-heterozygotes (number in parentheses indicates the 
total animals and wings scored). 
    Malformation   










Wing total (total 
wings scored)  
(Oregon R)+/+ Wildtype 0 (71) 0 0 0 (142) 
18-5/CR2 18-5 67 (24) 50 31 81 (48) 
Df(2R)PC4/CR2 18-5 71 (45) 35 29 64 (90) 
w, 12-5/CyH 12-5 17 (106) 46 43 89 (212) 
Rho72O/CR2 RhoA 50 (71) 33 19 52 (142) 
        
bw[1] bs[ba] blistered 0 (97) 0 0 0 (194) 
px1, bs3/  px1, bs3 blistered 0 (118) 0 0 0 (236) 
y w; P{w[+mC]=lacW}bs 
[k07909]/CyO blistered 0 (96) 0 0 0 (192) 
        
y,w{P[Limk1,EYO8757]} LimK 1 (399) 3 8 11 (798) 
        
Pak6/TM3,Sb1 Pak 0 (44) 0 0 0 (88) 
Pak11/TM3,Sb1 Pak 0 (30) 0 0 0 (60) 
        
y1, w*, Cdc421/FM6 Cdc42 0 (44) 0 41 41 (88) 
y1,w*,Cdc422P{neoFRT}19A Cdc42 0 (48) 4 9 13 (96) 
y1,w*,Cdc423/FM6 Cdc42 0 (48) 0 53 53 (96) 
y,w,Cdc424P{ry[+t7.2]}/FM6 Cdc42 0 (12) 0 17 17 (24) 
        
w67C23 P{lacW}RalaG0501/ FM7c Rala 0 (84) 0 0 0 (168) 
w67C23 P{lacW}RalaG0174/ FM7c Rala 0 (29) 0 0 0 (58) 
w67c23 P{lacW}RalaG0373/ FM7c Rala 0 (31) 0 0 0 (62) 
        
P{GT1}RglBG02025/ TM3,Sb1,Ser1 Rgl 0 (48) 0 0 0 (98) 
Pbac{Rgl} Rgl 0 (43) 0 0 0 (86) 
        
w[1118]; PBac{w]}Rlip[c02656] Rlip 0 (29) 0 0 0 (58) 
Df(3r)Exe16272(Rlip)/TM6B Rlip 2 (55) 0 0 0 (110) 
        
Df(2R)Egfr18, b[1] pr[1] 
cn[1]/CyO, bw[1] Egfr 3 (37) 3 0 3 (74) 
Egfrt1 bw1/CyO Egfr 0 (30) 0 0 0 (60) 
cn[1] Egfr[f2] bw[1] sp[1]/CyO Egfr 0 (46) 0 0 0 (92) 
Egfr[f24]/T(2;3)TSTL, CyO: 
TM6B, Tb[1] Egfr 0 (51) 0 0 0 (102) 
y w; P{wlacW}Egfr/CyO Egfr 0 (34) 0 0 0(68) 
Sequencing of DRal GEFmeso in 18-5 homozygotes 
A candidate gene located within the region in which 18-5 is located is the gene 
encoding GEFmeso (CG30115 in figure 16). GEFmeso encodes a guanine exchange 
factor which regulates the Ral GTPase and has also been shown to bind the Rho family 
member Cdc42. Moreover, RNAi experiments targeting GEFmeso have been shown to 
exhibit an ectopic crossvein wing phenotype similar to that of 18-5 [53]. 
GEFmeso is a guanine nucleotide exchange factor identified as a Ral GTPase 
activator. The protein has two isoforms, GEFmeso (1237 amino acids) and GEFmeso-
short (731 amino acids) (Figure 18, [53]). The GEFmeso-short lacks the Dbl-homology 
(DH) and Pleckstrin homology (PH) domains found in GEFmeso. The DH domain is 
responsible for the catalytic activity driving the GDT-GTP exchange within GTPases, 
while the PH domain binds lipids and is necessary for membrane localization to occur. 
GEFmeso also contains a Ral GTPase binding region (RBR) and other protein domains 
including putative PEST and PDZ motifs as well as several proline rich regions. The PDZ 
domain is most likely required for protein-protein interactions [54]. 
 
 




To investigate the possibility that GEFmeso is 18-5; I cloned and sequenced 
GEFmeso from 18-5 and 12-5 (as a progenitor control) homozygotes. To accomplish this, 
I used 24 forward and reverse primers to PCR amplify the coding region of the gene 
(Table 2). The primers amplified the coding region in 500-700 bp fragments and all 
primers overlapped by an average of 150 bp for complete coverage. Two large introns 
between primers 5 and 6 and between 8 and 9 were omitted (Figure 19), but the PCR 
amplification extended into the intron to include possible splice site mutations. 
 
 
Figure 19: Locations of primers used for the PCR amplification of GEFmeso.  
The number indicates the primer used (Table 2) and the forward and reverse primers are labeled 
with an F and R respectively. The blue blocks indicate exons while the lines connecting the exons represent 
introns. 
Upon initial sequencing of 18-5, three mutations were observed in the GEFmeso 
sequence. However, two of the mutations are point mutations which were not observed in 
the second sequencing of the same region from 18-5 homozygotes, nor were they 
observed in the sequencing of the 12-5 progenitor line. A third mutation observed was an 
insertion of three amino acids and was identified in two sequencing attempts of 18-5 as 
well as in the sequence of 12-5.  
One point mutation identified in the initial sequencing of GEFmeso is a change 
from a cytosine to an adenine. This sequence alteration results in an amino acid 
substitution from a proline to a threonine. The alteration is located in the amino terminal 
end of the protein just 26 amino acids from the start of the protein in an unconserved 
region of the protein. This proline to threonine substitution was observed only in the 
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initial 18-5 sequencing reaction, and not in the second 18-5 sequencing reaction or the 
sequencing of 12-5. 
A second mutation is point mutation causing a change from a thymine to a 
cytosine resulting in a stop codon changing to a codon coding for glutamine. This change 
is significant because it ultimately results in the addition of 17 amino acids attached to 
the carboxyl end of the protein which encodes a putative PDZ domain. However, this 
mutation resulting in stop codon alteration was observed only in the initial sequencing 
reaction of 18-5, but not in the additional sequencing reactions nor was the mutation 
observed in the sequencing of 12-5. 
A third mutation is a nine base-pair insertion located near the carboxyl terminal 
end of the GEFmeso protein (Figure 20). The nine base-pair insertion results in a three 
amino acid insertion following a valine at position 1139 of the protein sequence. The 
three amino acid insertion includes an aspartic acid followed by two proline residues. 
This insertion is not located within a conserved region, but was observed in four different 
sequencing reactions of 18-5 and two different reactions from 12-5 (Figure 20). 
Therefore, the insertion was present within the progenitor line used for the EMS screen or 
the 18-5 and 12-5 mutations are the same allele of the GEFmeso gene. 
 
Figure 20: Image showing the nine bp insertion in GEFmeso gene sequenced from 18-5 and 12-5 
homozygotes (left). This insertion results in a three amino acid insertion of aspartic acid and two proline 
residues into the GEFmeso protein (right).  
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Genetic interaction studies place 18-5 at or above Drok in the RhoA pathway 
Myosin phosphatase and slingshot mutations suppress leg and wing 
malformation phenotypes exhibited by RhoA72O, +/+, 18-5 double heterozygotes.  
Genetic interactions between positive regulators of the RhoA pathway typically result in 
an increased level of leg and wing malformations. Recently, we have discovered 
(R.Ruggiero, personal communication) that an increase in malformation caused by 
mutations in two positive regulators of the pathway can be suppressed by the addition of 
a third site mutation in a negative pathway regulator [55]. This assay offers an excellent 
opportunity to determine where novel members of the RhoA pathway act within the 
pathway (see below). In order to determine where the 18-5 locus acts in the RhoA 
pathway, I utilized a third site suppression analysis. 
RhoA72O is a putative null mutation resulting from the imprecise excision of a P-
element insertion into the RhoA GTPase locus [32]. 18-5 and RhoA72O interact strongly in 
a heterozygous condition and exhibit wing and leg malformations (Table 8; [12]). Myosin 
phosphatase negatively regulates nonmuscle myosin II through the dephosphorylation of 
myosin regulatory light chain (Figure 21; [55]). The myosin binding subunit (MBS) of 
myosin phosphatase regulates the catalytic subunit of myosin phosphatase in response to 
upstream signals. A mutated form of Drosophila myosin binding subunit (DMbs3) is a 
homozygous lethal EMS mutation. DMbs functions antagonistically to the RhoA 
signaling pathway and has been shown to suppress malformation of mutations in many 
RhoA pathway members including zipEbr, DRhoGEF2 and DRhoA720 [55].  
  
Figure 21: Model of RhoA mediated signaling in imaginal discs. 
 
Additionally, cofilin phosphatase (ssh) acts antagonistically on the Lim kinase 
side of the pathway to regulate cofilin phosphorylation, thereby regulating actin 
filamentation (Figure 21; [40, 56]). 18-5 and RhoA72O trans-heterozygotes normally 
express 50% leg malformation and 52% total wing malformation. The total wing 
malformation can be separated into 33% general wing malformation represented by 
crumpled or blistered wings and 19% exhibiting extra crossveins.  
However, when a third mutation such as ssh or Mbs3 is carried by 18-5/Rho72O 
trans-heterozygotes, the level of malformation is suppressed (Table 9). For example, the 
addition of the ssh acts to suppress leg and wing malformation normally observed in 18-
5/Rho72O trans-heterozygotes. In 18-5, Rho72O, and ssh triple heterozygotes, the total leg 
malformation is reduced to 12% while the total wing malformation is reduced to 14%, 
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approximately a four-fold suppression of each malformation (Table 9). Furthermore, in 
the 18-5, Rho72O, and ssh triple heterozygotes, the percent of wings exhibiting crumpled 
or blistered wings is reduced to 6% while the percent of animals exhibiting ectopic 
crossveins is 8% (over 5 and 2-fold suppression respectively). 
A similar pattern of suppression is observed when an Mbs mutant is used to 
suppress the malformed phenotype associated with RhoA72O/18-5 trans-heterozygote 
animals (Table 9). While the amount of leg malformation is similarly reduced to 12% (4-
fold suppression), the total wing malformation only reduced to 26% (2-fold suppression), 
with 7% (5-fold suppression) exhibiting crumpled or blistered wings and no suppression 
of the ectopic crossvein phenotype. 
Table 9: Suppression analysis of 18-5 malformation by cofilin phosphatase (ssh) and the myosin 
binding subunit of myosin phosphatase (Mbs3).  
See text for discussion. 
Genotype Malformation type 
% Malformation 
(Total animals scored for leg malformation) 
(Total number of individual wings scored) 
18-5/RhoA72O Leg 50 (71 total animals scored) 
18-5/RhoA72O Total malformed wing 52 (142 total wings scored) 
18-5/RhoA72O Crumpled wing 33 
18-5/RhoA72O Extra crossveins 19 
18-5/RhoA72O; ssh/TM2 Leg 12 (55) 
18-5/RhoA72O; ssh/TM2 Total malformed wing 14 (110) 
18-5/RhoA72O; ssh/TM2 Crumpled wing 6 
18-5/RhoA72O; ssh/TM2 Extra crossveins 8 
18-5/RhoA72O; Mbs3/TM2 Leg 12 (39) 
18-5/RhoA72O; Mbs3/TM2 Total malformed wing 26 (78) 
18-5/RhoA72O; Mbs3/TM2 Crumpled wing 7 
18-5/RhoA72O; Mbs3/TM2 Extra crossveins 19 
 
This suppression analysis indicates that the 18-5 gene product is active within the 
RhoA signaling pathway at a location even with or upstream of Drosophila Rho kinase 
(Drok). Drok is a kinase which represents the branch point within the RhoA signaling 
hierarchy where the signaling pathway bifurcates and results in the activation of the Lim 
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kinase and myosin II heavy chain branches of the pathway (Figure 21). Moreover, this 
analysis indicates that ectopic crossvein formation is regulated by the Lim kinase branch 
of the pathway, whereas both branches of the RhoA pathway regulate leg malformation 
and the crumpled wing phenotype. 
Deficiency mapping of 12-5  
Deficiencies which interact genetically with RhoA and Stubble fail to uncover 
the 12-5 gene.  An autosomal deletion genetic screen conducted in our laboratory to 
identify genomic regions that interact with Stubble or RhoA revealed 15 deficiencies 
located on the second chromosome which interact with one or the other of these loci 
(Nine of which have previously been shown to complement the 12-5 mutation; Callis, 
unpublished data). Because 12-5 also genetically interacts with Stubble and RhoA 
mutants [12], I asked whether one of the remaining interacting deficiencies deletes the 
12-5 locus. To investigate the possibility that one of these deficiencies does indeed delete 
the 12-5 gene, I crossed six deficiencies that had not previously been tested with the 12-5 
mutation (Table 10). Crosses were subsequently tested with 12-5 in a doubly 
heterozygous condition (i.e. deficiency/+, 12-5/+). If the deficiency deletes the 12-5 
locus, then the subsequent progeny carrying the deficiency and the 12-5 mutation will 
exhibit malformation phenotypes and possibly show a reduction in viability similar to a 
12-5 homozygote. 
Crosses were set up under standard vial crosses conditions and all F1 progeny 




Table 10: List of deficiencies and their locations which were complementation tested with 12-5. 
Crosses between female 12-5 mutants and male flies carrying deficiencies were set up under 
standard vial crosses conditions and all F1 progeny carrying the deficiency and the 12-5 mutation were 
scored for malformation and reduced viability. Two deficiencies, Df(2R)PC4 and Df(2R)Pu66 resulted in 
reduction in viability of the animals carrying 12-5 and the deficiency compared to sibling classes. 





Df(2L)net-PMF/SM6a 3638 21A1;21B7-8 Complement 
Df(2L)BSC16, net1 cn1/SM6a 6608 21C3-4;21C6-8 Complement 
Df(2L)BSC30/SM6a, bwk1 6999 34A3;34B7-9 Complement 
Df(2L)TE35BC-24, b1 pr1 pk1 cn1 
sp1/CyO 3588 35B4-6;35F1-7 Complement 
w1; Df(2R)Np5, In(2LR)w45-32n, 
cn1/CyO 3591 44F10;45D9-E1 Complement 
Df(2R)PC4/CyO 1547 55A1; 55F1--2 Malformation/reduced viability 
Df(2R)Pu66/CyO 6146 55D2; 55E2 Malformation/reduced viability 
 
Leg and wing malformation phenotypes were observed with two deficiencies on 
the right arm of the 2nd chromosome. Although not fully lethal, there is a reduction in 
viability of animals carrying the 12-5 mutation over deficiencies Df(2R)PC4 and 
Df(2R)Pu66 (Table 11). Notably, 18-5 is nearly fully lethal over Df(2R)PC4 and many of 
the 18-5/deficiency animals which survive, exhibit leg and wing malformations. 
 
Table 11: Table showing the viability of trans-heterozygote animals involving 12-5 or 18-5.  
The number represents the percent of the particular trans-heterozygotes which reach adulthood 
compared to sibling classes (number in parentheses represents the total number of trans-heterozygous 
animals scored). ND = not determined. 
   12-5/+ 18-5/+ 
 12-5/+ 10 (25)  
 18-5/+ 81 (106) 13 (24) 
 Df(2R)PC4/+ 60 (34) 12 (67) 




Further mapping of the 12-5 locus 
P-element recombination mapping indicates that the 12-5 gene is located 
within the cytogenetic region of 50-56 of the 2nd chromosome.  To confirm that the 12-
5 locus was indeed located in the 55 cytogenetic region, I conducted P-element 
recombination mapping as 12-5 mapping as described above. These experiments were 
performed at low resolution so that the entire second chromosome could be tested. 12-5 
mapping was conducted using the Baylor P-element mapping kit available from the 
Bloomington stock center. The P-element transposons in this collection are spaced at 
regular distances along the second chromosome (Table 12) and used to calculate the 
recombination distances between the P-element and the 12-5 mutation. 






Recombination in cM 
(total animals scored) 
P{SUPor-P}KG00569 13139 21B1 38.7 (486) 
P{SUPor-P}KG07698 15116 25A2 42.8 (822) 
P{SUPor-P}KG02201 14423 27E6 28.4 (930) 
P{SUPor-P}KG07111 14319 30C1 29.7 (814) 
P{SUPor-P}porin[KG09266] 16984 32B1 32.4 (830) 
P{SUPor-P}KG05572 13901 33A2 31.6 (1588) 
P{SUPor-P}CG6116[KG04163] 13360 34B4 32.2 (1247) 
P{SUPor-P}KG06763 14241 35B1 32.3 (788) 
P{SUPor-P}Tim17b2[KG07430] 14628 35D2 34.1 (1038) 
P{SUPor-P}KG08033 14931 36A10 29.9 (835) 
P{SUPor-P}KG02815 12989 36E3 28.8 (605) 
P{SUPor-P}CG10700[KG04903] 13530 37B13 27.3 (1635) 
P{SUPor-P}KG02566 13484 40F1 23.2 (1018) 
P{SUPor-P}KG05308 14438 41F3 25.4 (907) 
P{SUPor-P}KG01834 14580 43E11 24.3 (577) 
P{SUPor-P}CPTI[KG01596] 13731 47A11 26.6 (961) 
P{SUPor-P}KG04872 14107 49E1 24.2 (797) 
P{SUPor-P}aPKC[KG06602] 14239 51D6 15.7 (1358) 
P{SUPor-P}KG07568 15114 53A4 15.4 (762) 
y1; P{SUPor-P}KG04591/CyO, ry506 14100 55E6 8.6 (961) 
P{SUPor-P}KG07930 14672 55F8 13.4 (1411) 
P{SUPor-P}KG06675 14496 59C1 27.3 (932) 
P{SUPor-P}KG06046 14470 60F5 34.4 (1405) 
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The data collected from the crosses between 12-5 and the P-elements indicates 
that the mutation lies close to the 55E region where the lowest frequency of 
recombination is observed (Table 12; Figure 22). A 1 cM recombination distance 
between mutations within the center of the 2nd chromosome equates to approximately a 
350-400 kb distance within the genome sequence. Although the resolution of this initial 
P-element recombination mapping is inadequate for the precise location of the 12-5 locus 
this data indicates that the 12-5 mutation is located in an interval of approximately 2.6 
Mb near the 55E cytogenetic location (Figure 22). Further molecular mapping is required 
to identify the precise locus of the 12-5 mutation. 
Location 21 25 27 30 32 33 34 35 35 36 36 37 40   41 43 47 49 51 53 55 55 59 60 
cM 39 43 28 30 32 32 32 32 34 30 29 27 23   25 24 27 24 16 15 8 13 27 34 
 
Figure 22: Schematic of the second chromosome and the P-elements used to map 12-5. 
The schematic represents the P-elements located along the 2nd chromosome. The boxes in light 
blue depict the cytogenetic location of each insertion while the white boxes below indicate the percentage 
of recombination between each P-element and 12-5. The dark blue box represents the centromere.  
12-5 genetic interactions 
Similar to the 18-5 mutation, 12-5 interacts genetically with mutations in 
RhoA, Cdc42, and Lim kinase and exhibits weak interactions with mutations in Egfr 
and Pak, but not with blistered, Rgl, or Rlip mutants.  I conducted second-site non-
complementation tests between 12-5 and mutations in genes listed in table 13 in order to 
characterize the functional relationship between 12-5 and various mutations that possibly 
play a role in leg and wing epithelial morphogenesis. Because 12-5 also exhibits ectopic 
crossvein phenoytpes that are similar to the 18-5 mutant, it was important to investigate 
possible genetic interactions between 12-5 and many the same mutant alleles tested for 
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interactions with 18-5 (Table 13). The results show that 12-5 interacts weakly with Egfr, 
Cdc42, Lim kinase, and Pak, but does not exhibit any malformation phenotype with 
blistered (Table 13). 
I also investigated the genetic interactions between 12-5 and 18-5 and 12-5 and 
RhoA, in an effort to more thoroughly examining ectopic crossvein expression. I found 
that 12-5 interacts strongly with both 18-5 and RhoA72O with respect to ectopic crossvein 
formation. The trans-heterozygote 12-5/18-5 and 12-5/RhoA72O F1 progeny exhibit 
ectopic crossvein phenotypes (43% and 16% respectively) as well as leg (17% and 51% 
respectively) (Table 13).  
Finally, I analyzed the 12-5 genetic interactions with two deficiencies located in 
the 55DE region, Df(2R)Pu66 and Df(2R)PC4. I found that 12-5 interacts strongly with 
both deficiencies exhibiting severe leg and wing malformations (Table 13). Interestingly, 
Df(2R)Pu66 and Df(2R)PC4 have been shown to delete the 18-5 locus (Callis and von 
Kalm, unpublished data and see above) Overall, the genetic interactions are remarkably 











Table 13: Genetic interactions of the 12-5 mutation.  
All stocks shown were crossed to 12-5/CR2 and the trans-heterozygotes carrying the 12-5 
mutation and the mutation in the gene of interest were scored for leg and wing malformation. Numbers 
indicate the percent malformation observed in the trans-heterozygotes (number in parentheses indicates the 
total animals and wings scored). 
    Malformation   
Genotype of Stock/Cross 
Gene of 
Interest 










(Oregon R)+/+ Wildtype 0 (71) 0 0 0 (142) 
w, 12-5/CyH 12-5 80 (25) 36 54 90 (50) 
18-5/CR2* 18-5 17 (106) 46 43 89 (212) 
Df(2R)Pu66/CR2* 18-5 17 (44) 17 58 75 (88) 
Df(2R)PC4/CR2* 18-5 49 (34) 36 53 89 (68) 
Rho72O/CyO RhoA 51 (71) 35 16 51 (142) 
        
y,w{P[Limk1,EYO8757]} LimK 3 (236) 8 17 25 (472) 
        
Pak6/TM3,Sb1 Pak 0 (29) 3 0 3 (58) 
Pak11/TM3,Sb1 Pak 0 (28) 0 0 0 (56) 
        
y,w,Cdc424P{ry[+t7.2]=neoFRT}/FM6 Cdc42 0 (27) 0 17 17 (54) 
        
w67C23 P{lacW}RalaG0174/ FM7c Rala 0 (26) 0 0 0 (52) 
w67c23 P{lacW}RalaG0373/ FM7c Rala 0 (17) 0 0 0 (34) 
        
P{GT1}RglBG02025/ TM3,Sb1,Ser1 Rgl 0 (44) 0 0 0 (88) 
        
Df(2R)Egfr18, b[1] pr, cn,/CyO Egfr 7 (15) 8 0 8 (30) 
Egfrt1 bw1/CyO Egfr 0 (49) 0 0 0 (98) 
cn[1] Egfr[f2] bw[1] sp[1]/CyO Egfr 0 (39) 0 0 0 (78) 
Egfr[f24]/T(2;3), CyO: TM6B, Tb[1] Egfr 0 (29) 0 0 0 (58) 




Understanding the general mechanisms regulating epithelial morphogenesis is 
fundamental to the understanding the pathology of epithelia. Drosophila leg imaginal 
discs are an excellent system in which to study the basic principles of epithelial 
morphogenesis. Drosophila imaginal primordia give rise to most of the adult epithelial 
structures including the adult head, thorax and appendages, and external genitalia. 
Imaginal discs arise as invaginations of embryonic epithelium and grow by mitosis until 
metamorphosis, at which time substantial morphological changes occur. In leg imaginal 
discs, these morphological changes are coordinated by precise cell shape changes [9, 10, 
19]. These cell shape changes act to guide the morphogenesis of many tissues and organs. 
Specifically, in Drosophila, correct epithelial morphogenesis is crucial for the 
development of legs and wings. 
A number of genes controlling cell shape changes and presumably actin-myosin 
contractility are associated with the proper development of the Drosophila adult leg and 
wing. Two gene groups influencing leg and wing epithelial morphogenesis include the 
ecdysone hormone responsive genes and genes that are not directly regulated by 
ecdysone [11, 12, 21-23, 25, 49]. 
Three studies have provided evidence for ecdysone and RhoA mediated pathways 
acting in a coordinated effort to regulate imaginal disc epithelial morphogenesis [11, 12, 
48]. Consequently, the genes which interact genetically with both the ecdysone and RhoA 
pathway members are key to deciphering the regulatory mechanism guiding leg and wing 
epithelial morphogenesis. The 18-5 and 12-5 genes identified by our lab are significant in 
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that they have been shown to interact with both ecdysone activated Stubble locus as well 
as RhoA pathway members. The goal of this research is to gain a better understanding of 
18-5 and 12-5 in order to help elucidate the mechanism of interaction of steroid hormone 
and intracellular signaling regulating the process of epithelial morphogenesis. 
To identify the 18-5 and 12-5 genes I utilized a P-element recombination mapping 
technique to identify the precise location of these genes within the Drosophila genome 
[50]. Using this technique I have narrowed the molecular location of the 18-5 locus to an 
interval of 112 kb within the Drosophila genome. This 112 kb region contains 17 known 
and predicted genes. Additionally, I have also narrowed the location of the 12-5 mutation 
to a 2.6 Mb interval on the right arm of the 2nd chromosome.  
Phenotypic and mapping analysis identified a candidate gene for the 18-5 
mutation. This candidate gene was recently identified as a Ral GEF named GEFmeso 
[53]. Significantly, RNAi experiments targeting GEFmeso identified a mutant ectopic 
crossvein phenotype which is similar to that observed in 18-5 homozygotes. Moreover, 
GEFmeso has been shown to bind Cdc42 [53], a gene with which 18-5 interacts (Figure 
17). Therefore, I cloned and sequenced GEFmeso from 18-5 and 12-5 (as progenitor 
controls) homozygotes. The sequencing results were inconclusive and require further 
analysis. 
In order to further characterize the functions of the 18-5 and 12-5 loci, genetic 
interaction studies were performed. I found that 18-5 and 12-5 genetically interact with 
mutations in LIM kinase, but do not interact genetically with Pak, blistered (DSRF), or 
Ral GTPase. A gene known to play a role in longitudinal vein formation, Egfr [57], 
exhibited only minor genetic interactions with 18-5 and 12-5. Furthermore, I have shown 
that 18-5 and 12-5 interact with Cdc42 and exhibit ectopic wing crossveins. However, 
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animals heterozygous for 18-5, 12-5, or Cdc42 mutations do not show any leg 
malformation or crumpled wing phenotypes. 
Finally, to better understand the role of 18-5 within the RhoA signaling hierarchy, 
I have also conducted third site suppression analysis studies. I tested triple mutants 
carrying 18-5, RhoA720 and Mbs3 (all in heterozygous condition) as well as 18-5, RhoA720 
and ssh (also all in heterozygous condition). Myosin phosphatase (Mbs) and Slingshot 
(ssh) act antagonistically to regulate the RhoA signaling pathway [40, 55, 58]. 
Interestingly, the addition of third site mutations Mbs and ssh suppressed the leg and 
crumpled wing phenotypes normally exhibited in 18-5/RhoA72O trans-heterozygotes. 
However, the ectopic crossvein phenotype was only suppressed in combinations carrying 
a ssh mutation. This analysis indicates that with respect to most aspects of leg and wing 
morphogenesis, 18-5 acts at or above Drok in the RhoA pathway and that crossvein 
formation is regulated by the Limk/ssh branch of the pathway. 
Deficiency and recombination mapping of 18-5 
The P-element recombination mapping of 18-5 considerably narrowed the region 
in which it is located and as well as the number of possible gene candidates. The 55C9-
55D4 region of the 2nd chromosome contains a total of 17 genes. One discrepancy 
between the recombination and deficiency data is that the recombination data mapped the 
18-5 mutation to a region approximately 75 kb upstream from the left breakpoint of the 
smallest deficiency to uncover 18-5. This data interpreted literally, suggests that the 
mutation was mapped with deficiencies to the 55D region as well as further upstream to 
55C9-11 by recombination mapping.  
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The most likely explanation for this discrepancy is that the P-elements used for 
mapping were not close enough to the 18-5 locus to obtain sufficiently accurate 
resolution. Zhai et, al. (2003) achieved resolution to within 50 kb in situations where 
fewer than 10 recombinants per 10000 progeny were observed. In contrast, in my 
experiments, the lowest number of recombinants was 120 per 10,000 animals. This would 
presumably result in a decrease in resolution of the mapping recombination rate, thereby 
decreasing the accuracy of the mapping technique. In view of these limitations, resolution 
to within 75 kb of the closest deficiency breakpoint seems reasonable.  
The resolution could be increased through several methods. We could possibly 
create a new 18-5 allele with EMS which would exhibit either full lethality or exhibit a 
stronger mutant phenotype for scoring the escapers. Another option would be to utilize P-
elements which are closer to the 18-5 locus. The nearest P-elements used in my 
experiments were approximately 350 kb away from the projected location of the 18-5 
locus. The reason for choosing these P-elements was to ensure that we utilized P-
elements located to the left and right of the mutation. Choosing P-elements which are 
located at a distance of 100-150 kb away from the 18-5 locus would increase the 
resolution of the molecular mapping. Finally, another method for increasing the 
resolution would be to increase the number of crosses and animals scored. This would 
decrease the affect the escapers have on the overall calculations. 
To further elucidate the cause of the difference between the molecular mapping 
and P-element recombination data, I used several lethal insertions to more clearly identify 
the precise endpoints of the deficiencies. The deficiency Pu66 deletes the genomic region 
of 55D2-55E4. In an effort to determine if Df(2R)Pu66 actually deletes a portion of the 
chromosome further to the left of the published breakpoint, I crossed two lethal P-
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elements located at 55C9 and 55D1 to the deficiency. The data obtained indicate that the 
Pu66 deficiency had a left breakpoint which did not extend further upstream than 55D2.  
This results in three possible interpretations. First, this indicates that the 
resolution of the molecular mapping resulted in an incorrect position of the 18-5 mutation 
and the 18-5 locus is actually located within the region of the deficiency Df(2R)Pu66. A 
second interpretation is that the molecular mapping correctly positioned the 18-5 locus, 
but the deficiency deletes a gene which when carried as a trans-heterozygote with 18-5 
results in reduced viability and characteristic leg and wing malformations. Finally, the 
chromosome carrying the deficiency could possibly carry an additional mutation outside 
of the deleted region which acts similarly to reduce viability and cause the resultant 
malformation phenotypes. Clearly, further mapping experiments are needed to precisely 
locate the 18-5 gene. These could include either the P-element recombination mapping 
with necessary modifications, or possibly using another method such as the male P-
element recombination technique [59] which positions a gene to the right or left of a P-
element. 
18-5 genetic interactions 
While 18-5 heterozygotes do not exhibit leg or wing malformation, 18-5 
homozygous mutants often exhibit the characteristic leg malformations represented by 
shortened, twisted femurs (67%). Also, 18-5 homozygotes exhibit 81% overall wing 
malformation, of which, 50% are crumpled or blistered and 31% exhibit ectopic 
crossveins. 18-5 also interacts genetically with ecdysone activated Sb (34-37%) and 
RhoA pathway members such as RhoA (72-81%) and zipper (41%) [12]. I have futher 
identified 18-5 genetic interactions with an additional RhoA pathway member, Lim 
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kinase. 18-5/Lim kinase trans-heterozygotes exhibit a weak genetic interaction exhibiting 
11% total wing malformation. Additionally, suppression analysis places the 18-5 gene 
product within the RhoA signaling pathway at or above Drok (Table 9; Figure 21). This 
genetic evidence strongly suggests a role for 18-5 in the interaction of ecdysone activated 
stubble and RhoA regulation of leg and wing morphogenesis.  
Of particular interest a malformation phenotype often observed in 18-5 
homozygotes is the induction of ectopic crossveins (31%). Significantly, ectopic 
crossveins have also been exhibited in mutations in Cdc42, Lim kinase as well as RNAi 
experiments targeting GEFmeso [48, 51-53]. To investigate the role of 18-5 in the 
development of wing crossveins, I conducted many crosses specifically analyzing ectopic 
crossvein expression. I observed ectopic wing crossveins in 18-5/RhoA (19%) and 18-
5/12-5 (43%) trans-heterozygotes. Interestingly, 18-5/Lim kinase trans-heterozygotes 
exhibit a weak (8%) genetic interaction regarding ectopic wing crossveins, and 18-
5/Cdc42 trans-heterozygotes show weak (9%) to strong (53%) interactions regarding 
ectopic wing crossveins. Finally, third site suppression analysis indicates that ectopic 
crossvein formation is regulated by the Lim kinase branch of the pathway (Table 9; 
Figure 21). 
GEFmeso 
GEFmeso is a recently identified Drosophila Ral guanine exchange factor [53]. It 
has been shown to bind Cdc42 as well as DRal GTPase. Furthermore, in RNAi 
experiments targeting GEFmeso, investigators found an increase in ectopic crossvein 
formation. This phenotype has been observed in mutants of several other genes including, 
Cdc42, Egfr, RhoA, Sb, and Lim kinase (Table 8; [48, 51-53]. The ectopic crossvein 
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phenotype has also been observed in 18-5 (31%) and 12-5 (54%) homozygotes. 
Additionally, the GEFmeso gene is located within the Df(2R)Pu66 deficiency. This 
information suggested that GEFmeso was a good candidate to be the 18-5 locus. I tested 
this hypothesis by sequencing the gene from 18-5 homozygotes. Although the sequencing 
data for GEFmeso were inconclusive, they do not rule out GEFmeso as a candidate at this 
point. The initial sequencing identified three mutations (discussed below). Further 
analysis is required to fully elucidate potential sequence alterations in the GEFmeso gene 
of 18-5 homozygotes. 
Proline to threonine: The initial sequencing of 18-5 identified an amino acid 
change from a proline to a threonine. Although this amino acid change was not observed 
in the second sequencing reaction, it remains to be investigated if indeed it is a bona fide 
alteration to the sequence. This amino acid change could be of importance to the protein 
because threonine residues are susceptible to phosphorylation which could alter the 
conformation and hence, the catalytic activity of the protein. Although the putative 
proline to threonine substitution is not in a highly conserved domain such as the DH, PH 
or Ral binding region, if phosphorylated, it could potentially disrupt the activity of the 
protein. 
Termination codon alteration: A second mutation found in the initial 
sequencing, but not observed in the second sequencing of 18-5 is the change of a stop 
codon to a codon coding for a glutamine. The change of a stop codon to a glutamine 
results in the lengthening of the protein by 17 amino acids. Recall that the C-terminus of 
GEFmeso is thought to contain a PDZ domain. The PDZ domain is responsible for 
protein interactions. An addition to the C-terminus could alter the protein-protein binding 
of the GEF and interrupt specific localization of the protein needed for correct function. 
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Insertion: The three amino acid insertion at location 1139 of the 1239 amino acid 
protein is not located in any region of the protein that is relevant to binding or activation, 
however, it does occur near a proline rich region and the putative PDZ domain at the 
carboxyl end of the protein. However, the insertion was also observed in 12-5 
homozygotes as well as 18-5 homozygotes, indicating that it existed in the progenitor 
stock from which the 18-5 and 12-5 mutations were isolated (Figure 20). 
Further sequence analysis must be completed before ruling out GEFmeso as a 
candidate for the 18-5 mutation. First, in the unlikely event that the initial sequencing of 
18-5 revealed a true mutation, and the second sequencing reactions revealing a wildtype 
sequence were incorrect, I will sequence the relevant regions a third time to verify the 
results. Furthermore, I could sequence a third member of the progenitor line, 31-6, to 
compare to the initial sequencing of GEFmeso in 18-5 mutants. An alternative would be 
to determine if GEFmeso RNA is altered in quantity or size in the 18-5 mutant. Finally, 
another approach would be to conduct rescue experiments using genomic fragments from 
within the 112 kb region. 
Possibility that 18-5 and 12-5 are alleles warrants additional analysis 
The 12-5 mutation exhibits many similarities to the 18-5 mutation raising the 
possibility that 12-5 is allelic to 18-5. Although the possibility is speculative at this time, 
the evidence supporting the possibility warrants further investigation.  
Genetic interactions:  18-5 and 12-5 both interact strongly with RhoA, and 
weakly to moderately with zip and Sb (Table 1; [12]. Additionally, 18-5 and 12-5 also 
exhibit similar genetic interactions regarding ectopic crossvein expression with LIM 
kinase (8% and 17% respectively), and both 18-5 and 12-5 each express ectopic 
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crossveins (17% for both mutations) as trans-heterozygotes with Cdc424. Furthermore, 
12-5 and 18-5 mutants both exhibit strong genetic interactions and reduced viability with 
the deficiency Df(2R)PC4. Altogether, this data raises the possibility that the 12-5 
mutation is an allele of 18-5 however, further genetic interaction studies are necessary. 
Pupal lethality and reduced viability:  The 18-5 and 12-5 mutants both exhibit 
pupal lethality as homozygotes (Callis and von Kalm, data not shown), and as reported 
here and by Bayer et, al (2003), the 18-5  +/+  12-5 double heterozygotes show reduced 
viability. The reduced viability (only 81% reach adulthood) of the double heterozygotes 
also is suggestive of lethality during pupal phase development. 
Molecular mapping:  18-5 has been narrowed to the interval of 55C9-10-55D4 
and preliminary evidence suggests that 12-5 could be mapping to the same locus. 
Interestingly, the 12-5 mutation was mapped to a cytogenetic region near 55E of the 
Drosophila genome. However, further mapping must be conducted to narrow the 12-5 
mapping interval as many genes are located in this region of the Drosophila genome 
including genes encoding RhoA GTPase and Myosin light chain kinase. Altogether, this 
evidence, although not concrete, is supportive of the possibility that 12-5 and 18-5 are 
alleles and warrants further analysis. 
Broader Significance 
Several recent studies have identified an interesting intersection between systemic 
ecdysone steroid hormone signaling and the cell autonomous intracellular RhoA 
signaling pathway [11, 12, 25, 27]. Currently there is a major gap in the understanding of 
how systemic hormone signals regulate intracellular signaling pathways during 
development. For example, estrogen and progesterone have been shown to play an 
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important role in the sprouting morphogenesis occurring during alveologenesis in 
mammary gland development of rats and mice [17]. Estrogen and progesterone activate 
genes such as IGF-1 and Wnt-4 via a mechanism that is poorly defined. IGF-1 and Wnt-4 
are necessary for correct branching morphogenesis of the developing mammary gland, 
however, the specific pathways activated by these growth factors has not been established 
[16]. In the developing murine urethra, androgenic hormones regulate Fgfr, which is 
essential for the development of the urethral tube [4]. However the mechanism by which 
Fgfr is activated is again poorly understood, and although Fgfr is presumed to activate 
Receptor Tyrosine Kinase signaling, this has not been demonstrated. 
In a vertebrate system somewhat analogous to Drosophila leg development, 
murine prostate gland development has been shown to be regulated by androgenic 
hormones. Interestingly, studies have shown that during prostate gland development, 
androgenic hormones regulate the TMPRSS2 type II transmembrane serine protease [44]. 
Although the function of TMPRSS2 has not been fully elucidated at this time, the TTSP 
is proteolytically autoactivated in response to androgenic hormones and regulates 
intracellular signaling via PAR2 [44]. Significantly, TMPRSS2 is highly expressed in 
prostate as well as colonic cancers indicating that elucidation of the mechanism of 
hormonally induced intracellular signaling role by TMPRSS2 is a question of 
considerable clinical significance. In this context it is also clear that understanding the 
nature of the interaction between ecdysone and intracellular signaling pathways in 
Drosophila imaginal discs is likely to contribute in a fundamental way to a broader 
understanding of hormonal involvement in vertebrate development and pathology. 
 64
Future Directions 
Identification of the 18-5 gene product: If it is concluded upon additional 
GEFmeso sequencing, that GEFmeso is not 18-5, then different strategies must be 
utilized to identify the 18-5 gene. Additional P-element recombination mapping is not an 
ideal method due to the difficulties in separating white eye recombinants from white eye 
non-recombinants (see methods). Therefore, alternative approaches must be applied to 
identify the 18-5 gene. One strategy to consider will be to create designer deletions with 
hobo elements to better define the region containing the 18-5 gene. Overlapping deletions 
created by the imprecise excision of hobo elements located less than 200 kb from the 18-
5 locus would help determine the precise region in which 18-5 is located. Additionally, 
presuming that there is a reduction in size or quantity of 18-5 RNA, we could analyze the 
RNA expression of the genes located in the small region narrowed down by the 
molecular mapping. We will conduct northern blots of genes of wildtype flies and 
compare the expression patterns to the same genes from 18-5 homozygotes. Finally 
another technique is to conduct genomic rescue of the 18-5 malformation phenotype. 
This technique would allow us to take approximately 10 kb fragments across the 150 kb 
region and use them for genomic rescue of the mutant phenotype. 
Phenotypic characterization of 18-5: Further characterization of the 18-5 
phenotype will improve our understanding of the role of 18-5 in Drosophila 
development. For example, investigations into the role of 18-5 in embryonic, larval and 
pupal phase development will lead to a better understanding of the spatial and temporal 
aspects of 18-5 in Drosophila development. Additionally, once the gene product is 
known, we will be able to formulate a hypothesis to test the role of 18-5 in RhoA 
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signaling, however, experiments to be conducted at this point remain contingent upon the 
actual 18-5 gene product. Finally, we will conduct experiments to determine whether 18-
5 gene is ecdysone responsive. 
18-5 Genetic interactions: Further experiments are needed to investigate the 
genetic relationships between 18-5 and other genes with a role in the development of 
Drosophila legs and wings and in particular wing crossvein development. For example, 
further investigation of possible interactions between 18-5 and Cdc42, Pak, and Lim 
kinase must be conducted for a better understanding of the respective genetic 
relationships regarding wing crossvein development. For example, Pak is a downstream 
effector of Cdc42 and furthermore, Pak has been shown to activate Lim kinase. This 
represents a possible signaling pathway regulating wing crossvein development. I have 
shown that 18-5 interacts genetically with Cdc42 and Lim kinase with the respective 
trans-heterozygotes exhibiting ectopic wing crossveins.  
Therefore it is important to further investigate the genetic relationships between 
18-5 and Cdc42, Pak and Lim kinase, because this represents a possible RhoA-Cdc42 
connection involving crosstalk between the Cdc42 and RhoA GTPase signaling 
hierarchies (see figure 21). Interestingly, Cdc42 does not interact with RhoA or other 
members of the RhoA signaling pathway in leg development. However, Cdc42 interacts 
with Lim kinase and 18-5 and RhoA interacts with Sb and 18-5 in wing crossvein 
development. It remains to be tested whether RhoA interacts with other members of the 
RhoA pathway or Cdc42 in wing crossvein development. Further experiments 
investigating this apparent signaling network are needed to fully understand the role of 
18-5 in RhoA signaling. Finally, if GEFmeso is indeed 18-5, then this genetic interaction 
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data should help understand the role of this Guanine nucleotide exchange factor in the 
developing leg and wing. 
12-5 mapping: The rough mapping of the 12-5 locus narrowed the region 
significantly, but further mapping experiments remain necessary to clearly identify the 
12-5 gene. This mapping will be conducted using the P-element recombination mapping 
technique used to map 18-5 (see methods). If the additional P-element recombination 
mapping fails to identify the 12-5 gene locus, then we will utilize the alternative 
techniques described for the identification of 18-5 in the case that GEFmeso is not 18-5. 
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